I have Exam internal medicine subject 3rd year 1. Parasitic Infections 2. Review of Respiratory Physiology Approach to Patients with Disease of the Respiratory Tract - 3. Bronchiectasis Lung Abscess Cystic Fibrosis 4. Gram Negative II IDS Gram Negative Infections: Meningococcal, Gonococcal, HACEK Infections 5. Fungal Infections can u teach me all these topics according to the filei uploaded

Reading File

Running Command

python3 << 'EOF' import pdfplumber import os base = "/tmp/workspace/attachments/592e472b-2d54-4d44-a1f8-f4a538c0d0e0/" files = sorted(os.listdir(base)) print("Files found:") for f in files: path = os.path.join(base, f) try: with pdfplumber.open(path) as pdf: pages = len(pdf.pages) # Get first page text to identify content first_text = pdf.pages[0].extract_text() or "" print(f"\n--- {f} ---") print(f"Pages: {pages}") print(f"First 500 chars:\n{first_text[:500]}") except Exception as e: print(f"Error with {f}: {e}") EOF

Running Command

python3 << 'EOF' import pdfplumber base = "/tmp/workspace/attachments/592e472b-2d54-4d44-a1f8-f4a538c0d0e0/" # File (1) = Parasitic Infections intro + PCP # File (main) = Parasitic Infections tables # File (5) = Respiratory Physiology + Approach # File (4) = Meningococcal # File (3) = Gonococcal # File (2) = HACEK # 5_619... = Lung Abscess # Extract Parasitic Infections from file (1) with pdfplumber.open(base + "22nd_Ed_Harrison's_Principles_of_Internal_Medicine_260622_093343 (1).pdf") as pdf: text = "" for page in pdf.pages: t = page.extract_text() if t: text += t + "\n\n" print("=== PARASITIC INFECTIONS (1) ===") print(text[:8000]) EOF

Running Command

python3 << 'EOF' import pdfplumber base = "/tmp/workspace/attachments/592e472b-2d54-4d44-a1f8-f4a538c0d0e0/" # Extract all files and save to /tmp/workspace/ files = { "parasitic_main": "22nd_Ed_Harrison's_Principles_of_Internal_Medicine_260622_093343.pdf", "parasitic_1": "22nd_Ed_Harrison's_Principles_of_Internal_Medicine_260622_093343 (1).pdf", "hacek": "22nd_Ed_Harrison's_Principles_of_Internal_Medicine_260622_093343 (2).pdf", "gonococcal": "22nd_Ed_Harrison's_Principles_of_Internal_Medicine_260622_093343 (3).pdf", "meningococcal": "22nd_Ed_Harrison's_Principles_of_Internal_Medicine_260622_093343 (4).pdf", "respiratory": "22nd_Ed_Harrison's_Principles_of_Internal_Medicine_260622_093343 (5).pdf", "lung_abscess": "5_6195216580444430925.pdf" } os.makedirs("/tmp/workspace/exam_notes/", exist_ok=True) import os for key, fname in files.items(): path = base + fname with pdfplumber.open(path) as pdf: text = "" for page in pdf.pages: t = page.extract_text() if t: text += t + "\n\n" outpath = f"/tmp/workspace/exam_notes/{key}.txt" with open(outpath, "w") as f: f.write(text) print(f"Saved {key}: {len(text)} chars, {len(pdf.pages)} pages") EOF

Running Command

python3 << 'EOF' import pdfplumber import os base = "/tmp/workspace/attachments/592e472b-2d54-4d44-a1f8-f4a538c0d0e0/" files = { "parasitic_main": "22nd_Ed_Harrison's_Principles_of_Internal_Medicine_260622_093343.pdf", "parasitic_1": "22nd_Ed_Harrison's_Principles_of_Internal_Medicine_260622_093343 (1).pdf", "hacek": "22nd_Ed_Harrison's_Principles_of_Internal_Medicine_260622_093343 (2).pdf", "gonococcal": "22nd_Ed_Harrison's_Principles_of_Internal_Medicine_260622_093343 (3).pdf", "meningococcal": "22nd_Ed_Harrison's_Principles_of_Internal_Medicine_260622_093343 (4).pdf", "respiratory": "22nd_Ed_Harrison's_Principles_of_Internal_Medicine_260622_093343 (5).pdf", "lung_abscess": "5_6195216580444430925.pdf" } os.makedirs("/tmp/workspace/exam_notes/", exist_ok=True) for key, fname in files.items(): path = base + fname with pdfplumber.open(path) as pdf: text = "" for page in pdf.pages: t = page.extract_text() if t: text += t + "\n\n" outpath = f"/tmp/workspace/exam_notes/{key}.txt" with open(outpath, "w") as f: f.write(text) print(f"Saved {key}: {len(text)} chars") EOF

Reading File

Running Command

python3 << 'EOF' # Search for fungal infection content in the files import os base = "/tmp/workspace/exam_notes/" for fname in os.listdir(base): with open(base + fname) as f: text = f.read() if "fungi" in text.lower() or "fungal" in text.lower() or "candida" in text.lower() or "aspergill" in text.lower(): # Find where idx = text.lower().find("fungal") if idx == -1: idx = text.lower().find("fungi") print(f"\n=== {fname} has fungal content at char {idx} ===") print(text[max(0,idx-100):idx+500]) print("...") EOF

Running Command

python3 << 'EOF' # Search for Cystic fibrosis and pneumocystis content with open("/tmp/workspace/exam_notes/lung_abscess.txt") as f: text = f.read() # Find cystic fibrosis section idx = text.lower().find("cystic fibrosis") print("=== CYSTIC FIBROSIS (lung_abscess file) ===") print(text[idx:idx+3000]) EOF

Running Command

python3 << 'EOF' # Find CF dedicated section with open("/tmp/workspace/exam_notes/lung_abscess.txt") as f: text = f.read() # Find "CYSTIC FIBROSIS" as header idx = text.find("CYSTIC FIBROSIS\nDAVAO") if idx == -1: idx = text.find("CYSTIC FIBROSIS\n") print(f"Found at {idx}") print(text[idx:idx+4000]) EOF

Running Command

python3 << 'EOF' # Find pneumocystis / fungal sections with open("/tmp/workspace/exam_notes/parasitic_1.txt") as f: text = f.read() idx = text.lower().find("pneumocystis") print(f"Pneumocystis at {idx}") print(text[idx:idx+3000]) EOF

Running Command

python3 << 'EOF' # Find PCP section - it's in parasitic_1.txt with open("/tmp/workspace/exam_notes/parasitic_1.txt") as f: text = f.read() # Find PCP section idx = text.find("PCP\n") idx2 = text.find("Pneumocystis Infections") idx3 = text.find("pneumonia (PCP)") print(f"Pneumocystis Infections at {idx2}, PCP at {idx3}") # look for chapter 224 or 225 (PCP chapter number) idx4 = text.find("224") print(f"224 at {idx4}") # Show main content print(text[8000:12000]) EOF

Here is your complete 3rd Year Internal Medicine exam guide based directly on your uploaded files (Harrison's 22nd Edition + DMSF lecture slides by Dr. M. Platero).

📚 3RD YEAR INTERNAL MEDICINE EXAM NOTES

TOPIC 1: INTRODUCTION TO PARASITIC INFECTIONS

(Harrison's Chapter 228 + Chapter 229)

What is a Parasite?

From Greek parasitos - "one who eats at another's table." By convention, only helminths (worms) and protozoa are called parasites - NOT bacteria or viruses.

Parasites are eukaryotic - structurally similar to human cells, which historically made treatment difficult.
Modern research has provided safe and effective antiparasitic agents.

Two Major Categories

1. HELMINTHS (Worms)

Multicellular, often visible to naked eye
Two phyla:
- Platyhelminthes (flatworms) - tapeworms (cestodes) + flukes (trematodes)
- Nemathelminthes (roundworms/nematodes)

Key concept - Definitive vs Intermediate Host:

Situation	Human Role	What Happens
Humans ingest larvae	Definitive host	Larvae → adults in intestine; usually mild/asymptomatic
Humans ingest ova	Intermediate host	Ova → larvae → penetrate intestine → migrate to organs → severe disease

Exception: Strongyloides and Capillaria can complete their entire life cycle inside humans (auto-infection possible).

Important: Increases in helminth burden require repeated exogenous re-infection (no multiplication inside host). Permanent residents of endemic areas may have heavy infections; travelers with 1-2 exposures usually do not.

2. PROTOZOA

Microscopic, single-celled organisms
Can multiply within the human body → overwhelming infections
Two key immune evasion mechanisms:
- Antigenic variation - e.g., Trypanosoma brucei
- Intracellular survival - e.g., Plasmodium, Babesia, Cryptosporidium, Leishmania, Toxoplasma

Key concept: With protozoa, naive patients (first infection) are most severely affected. Partial immunity develops with repeated infections, limiting parasite numbers. This also promotes drug-resistant forms (especially in malaria).

Classified by site: intestinal protozoa, free-living amoeba, blood/tissue protozoa.

Helminthic Infections - The Major Groups

CESTODES (Tapeworms)

Intestinal tapeworms (acquired by eating undercooked meat):

Taenia saginata - beef tapeworm
Taenia solium - pork tapeworm (⚠️ ingesting T. solium OVA causes cysticercosis - somatic infection with larval invasion of tissues/brain)
Diphyllobothrium latum - fish tapeworm (causes vitamin B₁₂ deficiency)
Hymenolepis nana - grain beetles or human feces route

TREMATODES (Flukes)

Schistosoma mansoni / S. japonicum - mesentery → liver → portal hypertension, cirrhosis
S. haematobium - veins of ureter/bladder → urinary obstruction, renal damage, UTIs

KEY ROUNDWORMS

Intestinal:

Ascaris lumbricoides, Necator americanus (New World hookworm), Ancylostoma duodenale (Old World hookworm), Trichuris trichiura (whipworm), Enterobius vermicularis (pinworm), Strongyloides stercoralis
Combined, these infect ~900 million people globally
Most common where sanitation is poor / human feces used as fertilizer

Tissue/Systemic roundworms:

Trichinella spiralis - larvae penetrate intestine, migrate to skeletal muscle → myositis, palpebral (eyelid) swelling, high eosinophilia
Angiostrongylus cantonensis - most common parasitic cause of eosinophilic meningitis
Gnathostoma spinigerum - migrates to skin, eyes, meninges → boil-like lesions, eosinophilic meningitis (often more severe than Angiostrongylus)

Protozoal Infections - Key Organisms

INTESTINAL PROTOZOA

Entamoeba histolytica - the ONLY intestinal protozoan causing invasive disease (dysentery, bloody diarrhea, liver abscess)
- ⚠️ Cysts/trophozoites are identical to non-invasive E. dispar - cannot distinguish by morphology alone
- Slower onset, lower fever than bacterial dysentery
- Can disseminate hematogenously → liver abscess

BLOOD/TISSUE PROTOZOA

Organism	Disease	Transmission	Key Features
Plasmodium	Malaria	Mosquito (Anopheles)	Consider in ANY traveler from malarious area; now locally acquired in FL, TX, MD
P. vivax / P. ovale	Milder malaria	Mosquito	Persistent liver forms (hypnozoites) → require primaquine to prevent relapse
P. vivax	-	-	Cannot infect people lacking Duffy antigen (common in West Africans) → P. ovale fills this niche
Babesia	Babesiosis	Ixodid ticks	New England/Midwestern US; geographically limited; worse with splenectomy
T. brucei rhodesiense / gambiense	African sleeping sickness	Tsetse fly	Sub-Saharan Africa only; painful chancre, adenopathy, cyclical fevers; rhodesiense = early CNS; gambiense = late CNS
T. cruzi	Chagas disease	Reduviid bug feces	South/Central America; initial parasitemia → years of silence → megaesophagus, cardiomyopathy
Leishmania donovani	Visceral leishmaniasis (Kala-azar)	Sandfly	Tropics/subtropics; hepatosplenomegaly, fever, wasting; AIDS-defining infection

Immunocompromised Hosts (AIDS-defining parasites)

Leishmania, Toxoplasma, Cryptosporidium, Trypanosoma cruzi → disseminate in HIV/AIDS
Strongyloides → hyperinfection syndrome in immunocompromised
PCP (Pneumocystis jirovecii) - prophylaxis with TMP-SMX (first line)
- Alternative prophylaxis: dapsone, dapsone-pyrimethamine, atovaquone, aerosol pentamidine
- Prophylaxis threshold: >20 mg prednisone/day for 30 days OR other immunosuppressants (TNF inhibitors, rituximab, alemtuzumab)

Antiparasitic Drugs (Harrison's Chapter 229)

Drug	Mechanism	Uses	Key Toxicities
Albendazole	Binds β-tubulin → inhibits glucose uptake → starvation/death of parasite	Wide-spectrum nematodes, cysticercosis, hydatid disease	Nausea, alopecia, elevated LFTs; rare: leukopenia
Mebendazole	Same as albendazole	Ascariasis, enterobiasis, hookworm, trichuriasis	Diarrhea, abdominal pain; rare: agranulocytosis
Thiabendazole	Same class	Strongyloidiasis, cutaneous larva migrans	Frequent: anorexia, nausea, asparagus-like urine odor
Triclabendazole	-	Fascioliasis, paragonimiasis	Abdominal cramps, biliary colic
Diloxanide furoate	-	Amebiasis (luminal)	Frequent: flatulence
Benznidazole	-	Chagas disease	Rash, leukopenia, paresthesias

Key exam point: Albendazole - poorly GI absorbed (good for intestinal helminths); needs high-fat meal for tissue infections. Dexamethasone + praziquantel increase albendazole sulfoxide levels ~50%.

Parasites by Organ System - High-Yield Table

System	Symptoms	Parasites	Notes
Muscular	Myalgias, myositis	Trichinella	Palpebral swelling; HIGH eosinophilia
Bloodstream	Fever without localizing symptoms	Plasmodium	Any patient from malarious area
Bloodstream	Fever	Babesia	Worse with splenectomy
Bloodstream	Fever + adenopathy + chancre	T. brucei	Sub-Saharan Africa
Bloodstream	Fever + eosinophilia + lymphangitis	Filariae	Asia, India
Bloodstream	Hepatosplenomegaly + wasting	L. donovani	AIDS-defining

TOPIC 2: RESPIRATORY PHYSIOLOGY & APPROACH TO PATIENTS WITH RESPIRATORY DISEASE

(Harrison's Chapter 295 + 296)

Three Major Categories of Respiratory Disease

Category	Pathophysiology	Examples
Obstructive	Airway diseases - airflow resistance increased	Asthma, COPD, Bronchiectasis, Bronchiolitis
Restrictive	Reduced lung volumes	Parenchymal fibrosis, chest wall/pleura abnormalities, neuromuscular disease
Vascular	Pulmonary vessel disease	Pulmonary embolism, pulmonary hypertension, pulmonary venoocclusive disease

Also classified by gas exchange abnormalities: hypoxemia, hypercarbia, or combined impairment (many diseases do NOT show gas exchange abnormalities early).

Approach to the Patient - History

Cardinal Symptoms: Dyspnea and Cough

Quality of dyspnea gives clues:

"Chest tightness / inability to get a deep breath" → Obstructive (asthma, COPD)
"Air hunger / suffocation" → Congestive heart failure

Tempo of onset:

Acute SOB → sudden airway narrowing (laryngeal edema, bronchospasm, mucus plug), acute hypoxemia (pulmonary edema, pneumonia, PE), pneumothorax
Gradual progression with acute exacerbations → COPD or IPF
Intermittent episodes with specific triggers → Asthma

Key questions:

Factors that incite dyspnea
Factors that relieve dyspnea
Degree of activity causing SOB (gauge disability)
⚠️ Many patients adapt their activity level - always ask what they CAN and CANNOT do, not just if they are short of breath

Occupational/environmental history: Asbestosis, silicosis, hypersensitivity pneumonitis

Geographic exposure: Histoplasma capsulatum (specific geographic regions/climates)

Respiratory Physiology (Chapter 296)

Basic Function

Primary functions: oxygenate blood + eliminate CO₂
Occurs at alveoli: blood in alveolar capillaries separated from alveolar gas by extremely thin membrane of flattened endothelial and epithelial cells
Alveolar surface area: ~70 m² within a thoracic volume of ~7 L

Ventilation

Blood flow is unidirectional through pulmonary vasculature
Airflow reaches a dead end at alveolar walls → must be tidal (inflow and outflow alternating)
Both blood flow and ventilation distributed among millions of alveoli via multigeneration branching of pulmonary arteries AND bronchial airways

V/Q Matching

Ideal: ventilation of a given alveolus matches its perfusion
In health: alveoli vary in relative V/Q due to tube lengths, caliber, gravity, tidal pressure fluctuations
Disease: V/Q mismatch or shunt → increased (A-a)DO₂

Dynamic Airflow - The Bernoulli Effect (Key Concept)

During exhalation:

Gas leaving alveoli accelerates toward the mouth (central airways have greater cross-sectional area than peripheral, so gas must speed up)
Acceleration → reduces intraluminal pressure → reduces transmural pressure → airway narrows
This is the Bernoulli effect (same principle as airplane wing lift)
If you try to exhale harder → local velocity increases more → airway gets even smaller → no net increase in flow = Flow Limitation
Normal lungs have dynamic airflow limitation - maximal expiratory flow is fixed at any given lung volume

Clinical applications:

Emphysema: reduced lung recoil pressure → maximal expiratory flow falls → airflow limitation
Pulmonary fibrosis: increased lung recoil pressure → maximal expiratory flow elevated relative to lung volume
Asthma/Chronic bronchitis: narrowed airway lumen → reduced maximal flow
Tracheomalacia: excessive collapsibility → reduced maximal flow

During inspiration:

More negative pleural pressures → increase transmural pressure → airways expand
Inspiratory flow limitation rarely occurs from diffuse pulmonary disease
Exception: Extrathoracic airway narrowing (tracheal adenoma, posttracheostomy stricture) → inspiratory flow limitation

Spirometry Assessment

Patient inhales fully to TLC, then forcibly exhales to RV
Generates flow-volume loop
Maximal expiratory flow at any lung volume depends on: gas density, airway cross-section & distensibility, elastic recoil of lung, frictional pressure loss

Physical Examination

Breath sounds:

Absent/diminished over a lobe → consolidation or obstruction
Vesicular sounds absent elsewhere → emphysema (hyperinflated, decreased transmission)
Area of absent sounds → pneumothorax or pleural effusion

Diagnostic Testing

Pulmonary Function Tests (PFTs)

Assess degree of airflow obstruction, restriction, and impairment of diffusion
Spirometry: FEV₁, FVC, FEV₁/FVC ratio
Obstructive: FEV₁/FVC < 0.70
Restrictive: reduced TLC with preserved FEV₁/FVC ratio

Arterial Blood Gas (ABG)

Measures arterial PO₂ → calculate (A-a)DO₂
Increased (A-a)DO₂ → V/Q mismatch or shunt physiology
PCO₂ measurement → hypercarbia accompanies severe airway obstruction (COPD) or progressive restrictive physiology

Chest Imaging

Ultrasound - readily available; rapidly diagnoses pneumothorax, pleural effusion, consolidation
Plain chest X-ray (PA + lateral) - opacities, costophrenic angle blunting, masses, volume loss
- ⚠️ Many airway and pulmonary vascular diseases → normal CXR
CT chest - parenchymal processes, pleural disease, masses, large airways
CT with contrast - pulmonary vasculature for PE
CT + PET - metabolic activity of lesions (malignancy vs benign)

TOPIC 3: BRONCHIECTASIS, LUNG ABSCESS, CYSTIC FIBROSIS

(DMSF Lecture Slides - Dr. M. Platero)

BRONCHIECTASIS

Definition

Congenital or acquired disorder of large bronchi
Permanent, abnormal dilation and destruction of bronchial walls
Irreversible airway dilation (focal or diffuse)
Three morphologic types:
- Cylindrical/Tubular - most common
- Varicose
- Cystic

Etiology by Location

Location	Associated Causes
Upper lung fields	Cystic fibrosis (CF), postradiation fibrosis
Lower lung fields	Chronic recurrent aspiration, end-stage fibrosis (IPF - traction bronchiectasis), recurrent infections in hypogammaglobulinemia
Midlung fields	Nontuberculous mycobacteria (NTM/MAC), dyskinetic/immotile cilia syndrome
Central airways	ABPA, congenital (tracheobronchomegaly/Mounier-Kuhn syndrome, Williams-Campbell syndrome)
Idiopathic	25-50% of cases

Epidemiology: CF causes ~half of all bronchiectasis cases; MAC: nonsmoking women >50 years; incidence increases with age; women > men

Pathogenesis: "Vicious Cycle Hypothesis"

Susceptibility to infection + Poor mucociliary clearance → Microbial colonization → Infection → Airway damage → Worse clearance → More infection

Pseudomonas aeruginosa: propensity to colonize damaged airways, evades host defense
CF or dyskinetic cilia syndrome: even ONE severe infection (B. pertussis or Mycoplasma pneumoniae) → significant airway damage
Small airway inflammation → large airway wall destruction + dilation → loss of elastic tissue, smooth muscle, cartilage
Obstruction at smaller airways
Alpha-1 antitrypsin: neutralizes neutrophil elastases; deficiency → emphysema + bronchiectasis
Noninfectious bronchiectasis: immune-mediated reactions damaging bronchial wall
Traction bronchiectasis: parenchymal distortion from lung fibrosis pulling open airways

Clinical Manifestations

Most common: Persistent productive cough + thick, tenacious sputum
Physical exam: crackles, wheezing; some with digital clubbing
PFT: mild to moderate airflow obstruction
Acute exacerbations: increased sputum volume and purulence
⚠️ Fever and new infiltrates NOT typical (unlike pneumonia)

Diagnosis

Clinical (persistent cough + sputum) + radiographic features
CXR: Not sensitive; specific finding = "tram tracks" (dilated airways visible)
Chest CT: Most specific; imaging modality of choice
Signet ring sign on CT: enlarged airway (ring) next to normal-sized pulmonary artery (signet)

Treatment

Infectious bronchiectasis:

Antibiotic treatment targeting: H. influenzae, P. aeruginosa, NTM/MAC
Bronchial hygiene: hydration, mucolytics, aerosolization of bronchodilators + hyperosmolar agents (e.g., hypertonic saline), chest physiotherapy
Anti-inflammatory therapy: ICS (small trials show decreased dyspnea, reduced beta-agonist use, decreased sputum - but NO improvement in lung function or exacerbation rates)
Refractory cases: resection of focal suppuration; lung transplantation in advanced cases

Complications

Microbial resistance (repeated antibiotics)
Hemoptysis - if massive: intubate, protect non-bleeding lung, bronchial artery embolization, surgery (severe cases)

Prognosis

Variable, depends on etiology, exacerbation frequency, pathogens
Lung function decline similar to COPD

LUNG ABSCESS

Definition

Microbial infection resulting in necrosis and cavitation of pulmonary parenchyma
Usually a single dominant cavity >2 cm in diameter

Classification

By etiology:

Primary: Aspiration of anaerobic bacteria; NO underlying pulmonary/systemic condition
Secondary: Underlying condition - local (post-obstructive: tumor/foreign body) OR systemic (immunocompromised)

By duration:

Acute: <4-6 weeks
Chronic: >4-6 weeks (40% of cases)

Pathogenesis - Primary Lung Abscess

Source: aspiration of anaerobic/microaerophilic bacteria from gingival crevices in susceptible host
Involves large burden of aspirated material OR inability to clear bacterial load
Evolution:
1. Initial: pneumonitis (worsened by tissue damage from gastric acid)
2. Next 7-14 days: parenchymal necrosis and cavitation
3. Anaerobes produce more extensive tissue necrosis in polymicrobial infections

Pathogenesis - Secondary Lung Abscess

Bronchial obstruction (tumor/foreign body): failure to clear secretions → abscess
Immunosuppression: impaired host defenses
Septic embolism: from tricuspid valve endocarditis (usually S. aureus)
Lemierre's syndrome: pharyngeal infection by Fusobacterium necrophorum → spreads to neck and carotid sheath (which contains jugular vein) → septic thrombophlebitis → septic emboli

Pathology and Microbiology

Primary:

Location: dependent segments (posterior upper lobes + superior lower lobes)
Right lung > Left lung (less angulated right bronchus)
Microbiology: polymicrobial - anaerobes primarily + microaerophilic streptococci
Nonspecific lung abscess: no pathogen isolated in up to 40% - assume anaerobes
Putrid lung abscess: foul-smelling breath/sputum/empyema = essentially diagnostic of anaerobic abscess

Secondary:

Location: varies with underlying cause
Microbiology: broad spectrum - Pseudomonas aeruginosa, gram-negative rods most common
Immunosuppression (bone marrow/solid organ transplant): consider fungal infection
Culture mandatory for appropriate therapy

Clinical Manifestations

Initially resembles pneumonia: fever, cough, sputum, chest pain
Anaerobic lung abscess: more chronic/indolent - night sweats, fatigue, anemia
Putrid abscess: discolored, foul-smelling/tasting sputum
Non-anaerobic (S. aureus): more fulminant - high fever, rapid progression

Diagnosis

CXR/CT: cavitary lesion with air-fluid level
Low malignancy risk + aspiration risk factors (smoker <45 years) → empiric treatment first
High malignancy risk / immunocompromised / atypical presentation → early invasive diagnostics (bronchoscopy with biopsy, CT-guided needle aspiration)
⚠️ Always rule out TB in endemic areas or HIV patients

Treatment

Primary lung abscess (anaerobic):

IV beta-lactam/beta-lactamase inhibitor combination (e.g., ampicillin-sulbactam, amoxicillin-clavulanate) until stable → then oral amoxicillin-clavulanate
Duration: 3-4 weeks up to 14 weeks (until imaging shows clearing or regression to small scar)
Moxifloxacin (400 mg/d PO) as effective as ampicillin-sulbactam
⚠️ Metronidazole is NOT effective as a single agent

Secondary lung abscess:

Directed at identified pathogen
Relieve obstruction, treat underlying conditions

Important treatment points:

Defervescence may take up to 7 days even with appropriate therapy
10-20% may not respond (continuing fever, increasing abscess size)
Abscess >6-8 cm: less likely to respond to antibiotics alone
Non-responsive → surgical resection or percutaneous drainage (preferred for poor surgical candidates)

Complications

Persistent cystic changes (pneumatoceles) or bronchiectasis from large cavities
Empyema (pleural space extension)
Life-threatening hemoptysis
Massive aspiration of abscess contents

Prognosis

Primary: mortality ~2%
Secondary: may be as high as 75%
Poor prognostic factors: age >60, aerobic bacteria, sepsis at presentation, symptoms >8 weeks, abscess size >6 cm

Prevention

Protect airways, oral hygiene, minimize sedation, elevate head of bed for aspiration risk patients

CYSTIC FIBROSIS

Definition and Epidemiology

Most common cause of severe chronic lung disease in young adults
Most common fatal hereditary disorder of whites in the United States
Autosomal recessive - affects ~1 in 3,000 whites; 1 in 25 is a carrier
Less frequent: African-American (~1 in 10,000); Asian (~1 in 33,000)
CF-related gene: CFTR (Cystic Fibrosis Transmembrane Conductance Regulator)

CFTR Function (MUST KNOW)

CFTR is:

An integral membrane protein = epithelial anion channel
Passive conduit for chloride and bicarbonate transport across plasma membranes of epithelial tissues
Located in apical plasma membranes of acinar and epithelial cells
Regulates amount and composition of exocrine secretions

Respiratory mucosa:

CFTR provides sufficient depth of the periciliary fluid layer (PCL)
PCL → allows normal ciliary extension → normal mucociliary transport
CFTR-deficient airways: depleted PCL → ciliary collapse → failure to clear overlying mucus → mucus accumulates → infection

Exocrine glands:

CFTR drives apical chloride/bicarbonate secretion → fluid and electrolyte release into lumen → proper formation and transport of mucins
Failure → disruption of hydration and transport of glandular secretion

Key Alleles

F508del, G551D, truncation alleles = "severe" defects
Predictive of pancreatic insufficiency
Poor predictor of overall respiratory prognosis

Organ System Involvement

1. Respiratory (major morbidity/mortality)

Copious hyperviscous, adherent pulmonary secretions → difficult to clear
Complex bacterial flora: S. aureus, H. influenzae, P. aeruginosa
Inflammation + mucus + chronic infection → collateral tissue injury → decreased respiratory function
Pulmonary inflammation: aggressive, unrelenting, neutrophilic with release of proteases and oxidants → airway remodeling → bronchiectasis
Chronic respiratory infection → intense inflammation → macrophages/other cells → proinflammatory cytokines
Abnormal airway surface fluid composition (e.g., pH) → impaired bacterial killing

2. Pancreas

Profound exocrine pancreatic destruction: fibrotic scarring, fatty replacement, cyst proliferation, loss of acinar tissue
Tenacious exocrine secretions → obstruct pancreatic ducts → impair digestive enzyme flow to duodenum
Results: chronic malabsorption, poor growth, fat-soluble vitamin insufficiency, elevated serum immunoreactive trypsinogen (newborn screening test), loss of islet cell mass → CF-related diabetes mellitus

3. Liver

Obstruction of intrahepatic bile ducts + parenchymal fibrosis → multilobular cirrhosis

4. Intestine

Newborns: meconium ileus (failure to pass meconium)
Older individuals: distal intestinal obstructive syndrome (DIOS)

5. Reproductive

Men: complete involution of vas deferens → ~99% of males are infertile (spermatogenesis is intact)
Women: reproductive tract abnormalities → infertility

Other: Increased risk of osteopenia, arthropathies, GI tract malignancies

Diagnosis

Newborn screening is now most common route to diagnosis, confirmed by:
- CFTR mutation analysis
- Sweat chloride test (gold standard) - markedly elevated chloride levels; highly specific
- Mechanism: sweat ducts normally reabsorb chloride; CFTR malfunction → diminished chloride reabsorption → markedly elevated chloride in sweat

Pulmonary problems leading to diagnosis:

Chronic or recurrent productive cough
Recurrent pulmonary infections (especially with P. aeruginosa)

Treatment Principles

Modulator therapy: CFTR modulators (ivacaftor, elexacaftor-tezacaftor-ivacaftor) for eligible mutations - target the defective protein directly
Airway clearance techniques
Inhaled antibiotics (tobramycin, aztreonam) for P. aeruginosa
Pancreatic enzyme replacement
Fat-soluble vitamin supplementation
Lung transplantation for end-stage disease

TOPIC 4: GRAM-NEGATIVE INFECTIONS II - MENINGOCOCCAL, GONOCOCCAL, HACEK

(Harrison's Chapters 160, 161, 163)

MENINGOCOCCAL INFECTIONS

(Chapter 160)

Microbiology

Neisseria meningitidis - gram-negative diplococcus
12 capsular groups identified (A-C, X-Z, E, W, H-J, L)
6 major disease-causing groups: A, B, C, X, Y, W (formerly W135)

Capsular Group	Chemical Structure	Epidemiology
A	2-Acetamido-2-deoxy-D-mannopyranosyl phosphate	Epidemic - sub-Saharan Africa ("meningitis belt"); sporadic worldwide
B	α-2,8-N-acetylneuraminic acid	Sporadic worldwide; hyperendemic disease
C	α-2,9-O-acetylneuraminic acid	Small outbreaks + sporadic
Y	4-O-α-D-glucopyranosyl-N-acetylneuraminic acid	Sporadic + occasional institutional outbreaks
W	4-O-α-D-galactopyranosyl-N-acetylneuraminic acid	Sporadic; outbreaks at mass gatherings (Hajj); epidemics in sub-Saharan Africa
X	(α1→4) N-acetyl-D-glucosamine-1-phosphate	Sporadic + large outbreaks in meningitis belt

Iron dependency: Multiple specialized iron-regulated proteins in outer membrane (FetA, transferrin-binding proteins) - highlights organism's dependence on human iron sources

Epidemiology

Most infection: asymptomatic nasopharyngeal carriage
Closed/semi-closed communities: schools, colleges, universities, military training centers, refugee camps → clusters of disease
Sequence type 11 clone (mainly group C or W) - strongly linked to outbreaks over past 4 decades
Hajj pilgrimage 2000/2001: Group W outbreaks → vaccination now required for Saudi Arabia travel
Hyperendemic disease: ≥10 cases per 100,000 (U.S. Pacific Northwest, New Zealand, Normandy France - due to group B clones)
Sporadic: 0.0-2.8 per 100,000 in most countries
After nasopharyngeal acquisition → invasive disease in 1-10 days (usually <4 days)

Pathophysiology

Septicemia mechanism:
- Endothelial injury → capillary leak syndrome → hypovolemia
- Myocardial depression: hypovolemia + hypoxia + metabolic derangements (hypocalcemia) + cytokines (IL-6)
- Intravascular thrombosis + vasoconstriction + tissue edema + reduced cardiac output → widespread organ dysfunction
- High levels of PAI-1 → impairs fibrinolysis → DIC features
Meningitis mechanism:
- Local inflammatory response in meninges → release of cytokines
- Local endothelial injury → cerebral edema + raised intracranial pressure

Clinical Manifestations

Spectrum of presentations:

Asymptomatic carriage (most common)
Meningococcal meningitis (most common invasive form)
Meningococcal septicemia
Combined meningitis + septicemia
Occult bacteremia
Fulminant disease (death within hours)

Meningitis signs:

Neck stiffness, photophobia, decreased consciousness, seizures/status epilepticus, focal neurologic signs
⚠️ Classic signs often absent in infants/young children - present with fever, irritability, bulging fontanelle

Septicemia (up to 20% of cases):

May progress from nonspecific symptoms to death within hours
Mortality in children historically 25-40%
30-50% present with meningitis syndrome alone
Up to 40% of meningitis patients have some septicemia features
Deaths from meningitis alone: raised ICP - reduced consciousness, relative bradycardia + hypertension, focal neuro signs, abnormal posturing, brainstem involvement

Petechial/purpuric rash: Classic finding in septicemia - must recognize urgently

Prophylaxis

Reserved for: intimate/household contacts of index case + healthcare workers directly exposed to respiratory secretions
Mass prophylaxis (e.g., schools/colleges): limited data support, concerns about adverse events and resistance
Goal: eradicate colonization of close contacts with the same strain
Prophylaxis of all contacts simultaneously (avoid recolonization from untreated contacts)

Prophylactic agents:

Ceftriaxone (single IM/IV injection): 97% effective in carriage eradication; safe in all ages and pregnancy
Rifampin: widely used but not optimal - fails to eradicate in 15-20%, 4-dose regimen (compliance issue), emerging resistance
Ciprofloxacin/Ofloxacin: preferred in some countries; highly effective, oral route; NOT in pregnancy; resistance reported in North America, Europe, Asia

Immunization: For contacts of group A, B, C, Y, or W disease - MenACWY conjugate vaccine + MPSV4 available. New vaccines covering A, C, W, Y, X becoming available.

GONOCOCCAL INFECTIONS

(Chapter 161)

Definition

Gonorrhea: STI of epithelium
Common manifestations: cervicitis, urethritis, proctitis, conjunctivitis
If untreated → local complications:
- Female: endometritis, salpingitis, tubo-ovarian abscess, bartholinitis, peritonitis, perihepatitis (Fitz-Hugh-Curtis syndrome)
- Male: periurethritis, epididymitis
- Neonate: ophthalmia neonatorum (gonorrheal eye infection)
Disseminated gonococcal infection (DGI): skin lesions, tenosynovitis, septic arthritis; rarely endocarditis or meningitis

Microbiology

Neisseria gonorrhoeae - gram-negative, non-motile, non-spore-forming
Grows as monococci and diplococci
Exclusively a human pathogen
Average 3 genome copies per coccal unit → high level of antigenic variation → survival in host
Oxidase positive (like all Neisseria)
Distinguished by: growth on selective media + uses glucose but NOT maltose, sucrose, or lactose

Immunity

Partial immunity: bactericidal + opsonophagocytic antibodies to porin and LOS (lipooligosaccharide)
BUT women who acquire high levels of antibody to Rmp (Reduction Modifiable Protein/Protein III) → likely to become reinfected
- Rmp antibodies BLOCK effect of bactericidal antibodies to porin and LOS
- Rmp shows little interstrain variation → potentially blocks killing of all gonococci
- Rmp has homology to enterobacterial OmpA and meningococcal class 4 proteins → prior exposure may create blocking antibodies
Significant increase in porin-specific IL-4-producing CD4+ and CD8+ T lymphocytes seen in mucosal gonococcal disease

Antimicrobial Resistance - HIGH YIELD

Remarkable capacity to alter antigenic structure and adapt to changes
Cephalosporin resistance mechanism:
- Mutations in penA allele - encodes PBP2 (penicillin-binding protein 2); sequence can differ by 60-70 amino acids from wild-type
- mtrR gene mutations → increased drug efflux via MtrCDE efflux pump
- penB mutations → decreased drug influx through PorB
Cefixime (oral 3rd gen cephalosporin): Rising MICs + limited capacity to reach levels sufficiently above MICs in blood/urethra/cervix/pharynx → removed from first-line treatment
Ceftriaxone remains first-line (levels greatly exceed MICs at standard parenteral dose)
Spectinomycin: Alternative; no cross-resistance to other antibiotics; used in China as alternative; resistance outbreaks documented in Korea and England when used as primary treatment
Azithromycin resistance: Can result from ribosomal alterations

Treatment (Current)

First line: Ceftriaxone 500 mg IM (single dose) for uncomplicated urogenital/rectal gonorrhea
- If weight ≥150 kg: 1g ceftriaxone
For pharyngeal gonorrhea: higher doses required (harder to eradicate)
Dual therapy (adding azithromycin) has been debated due to rising azithromycin resistance
Always treat for Chlamydia co-infection (doxycycline 100 mg BID x 7 days)
DGI: Ceftriaxone IV/IM for 7+ days

HACEK GROUP INFECTIONS

(Chapter 163)

What is HACEK?

An acronym for fastidious gram-negative organisms that are part of the normal oropharyngeal flora and are associated primarily with endocarditis:

Letter	Organism
H	Haemophilus species (H. parainfluenzae)
A	Aggregatibacter species (A. actinomycetemcomitans, A. aphrophilus, A. paraphrophilus)
C	Cardiobacterium hominis
E	Eikenella corrodens
K	Kingella kingae

Key Features

Fastidious (difficult to culture - slow growth, special requirements)
Part of normal oropharyngeal flora
Primarily cause endocarditis (classically with negative initial cultures - "culture-negative endocarditis")
Large vegetations → risk of septic emboli (including CNS)
Aggregatibacter spp. = most common cause of HACEK endocarditis
- A. actinomycetemcomitans most frequently involved
- Associated with prosthetic valve endocarditis more than Haemophilus species
- Also causes soft tissue infections and abscesses

Haemophilus parainfluenzae Endocarditis

Large vegetations → septic emboli including central nervous system emboli
High incidence of complications: arterial emboli, CVAs, tricuspid insufficiency, congestive heart failure with cardiovascular collapse
Affects older children and adults; majority have preexisting valvular disease

HACEK Endocarditis - Treatment

Organisms	Preferred Therapy	Alternative	Notes
All HACEK (Haemophilus, Aggregatibacter, Cardiobacterium, Eikenella, Kingella)	Ceftriaxone 2 g/d	Ampicillin/sulbactam (3g q6h) OR Levofloxacin 750 mg/d	Ampicillin/sulbactam resistance described; Levofloxacin data limited - use when β-lactam intolerant; FQ NOT in <18 years

Ceftriaxone 2 g/d = first-line; favorable outcome in 80-90% of cases
Penicillin (16-18 million units q4h) or ampicillin (2g q4h) can be used if organism is susceptible
⚠️ Slow growth makes antimicrobial susceptibility testing difficult - β-lactamase production may not be detected
Eikenella corrodens is resistant to clindamycin (important to remember)

Moraxella catarrhalis (in same chapter)

Gram-negative coccus; normal upper airway flora
Causes: otitis media in children (15-20% of cases); COPD exacerbations in adults
Pathogenesis: viral URI (e.g., rhinovirus promotes adhesion) → migrates from nasopharynx to middle ear/sinuses
"Hockey puck sign": M. catarrhalis colonies can be slid across agar surface without disruption
After 48h growth: pink-colored, larger than neisserial colonies
>90% produce β-lactamase → resistant to amoxicillin
Susceptible to: amoxicillin-clavulanate, extended-spectrum cephalosporins, newer macrolides (azithromycin, clarithromycin), TMP-SMX, fluoroquinolones

TOPIC 5: FUNGAL INFECTIONS

Note: Your uploaded files do NOT contain a dedicated fungal infections chapter from Harrison's. The respiratory file briefly mentions Histoplasma capsulatum in the context of geographic exposure history, and the lung abscess slides note fungal infections in immunocompromised secondary abscesses. Below is a comprehensive summary based on Harrison's Chapter 210-218 standard content (the topic expected in 3rd year IM):

Overview of Medically Important Fungi

Category	Examples
Dimorphic fungi (mold in environment, yeast in body at 37°C)	Histoplasma, Coccidioides, Blastomyces, Paracoccidioides
Yeasts	Candida, Cryptococcus
Molds (non-dimorphic)	Aspergillus, Mucor, Rhizopus
Pneumocystis	Pneumocystis jirovecii

Pneumocystis jirovecii Pneumonia (PCP)

(Covered in your uploaded files - Chapter section on immunocompromised/parasitic)

Formerly classified as protozoan; now classified as fungus (ascomycete)
Almost exclusively in immunocompromised patients (HIV/AIDS, transplant, high-dose steroids, anti-TNF agents, rituximab, alemtuzumab, antithymocyte globulin)
Glucocorticoid threshold for prophylaxis: >20 mg prednisone/day for 30 days OR any combination with other immunosuppressants

Prophylaxis:

First line: TMP-SMX (one DS tablet daily or one SS tablet daily) - few PCP breakthroughs on this regimen
Alternatives (if TMP-SMX intolerant):
- Daily dapsone
- Weekly dapsone-pyrimethamine
- Atovaquone (effective + well-tolerated; oral only; absorption unpredictable with GI motility issues)
- Monthly aerosol pentamidine (not as effective as TMP-SMX; doesn't protect poorly-ventilated lung areas)
⚠️ Dapsone cross-reacts with sulfonamides in substantial fraction of patients
Gradual dose-escalation of TMP-SMX can sometimes be tolerated by hypersensitive patients

Treatment: TMP-SMX (high dose) + adjunctive prednisone for moderate-severe PCP (PaO₂ <70 mmHg or A-a gradient >35)

Histoplasmosis (Histoplasma capsulatum)

Dimorphic fungus; found in soil enriched with bird and bat droppings
Geographic distribution: Ohio and Mississippi River valleys (USA), parts of Central and South America
(Mentioned in your respiratory file as geographic exposure history example)

Clinical forms:

Asymptomatic (most cases in healthy hosts)
Acute pulmonary histoplasmosis: flu-like illness; self-limited in immunocompetent
Progressive disseminated histoplasmosis (PDH): in immunocompromised - fever, hepatosplenomegaly, pancytopenia, skin lesions, oral ulcers; can be AIDS-defining
Chronic cavitary histoplasmosis: resembles TB; upper lobe cavitary lesions

Diagnosis: Urine/serum Histoplasma antigen (most sensitive, especially for disseminated); culture; serology

Treatment: Itraconazole (mild-moderate); Amphotericin B liposomal (severe/disseminated)

Candidiasis (Candida species)

Most common opportunistic fungal infection
C. albicans most common; also C. glabrata, C. tropicalis, C. parapsilosis, C. krusei

Risk factors: Broad-spectrum antibiotics, central venous catheters, TPN, neutropenia, immunosuppression, diabetes, mucosal disruption

Clinical forms:

Form	Features
Oropharyngeal (thrush)	White plaques on buccal mucosa/tongue that scrape off; HIV/AIDS, steroid inhalers
Esophageal	Dysphagia, odynophagia; AIDS-defining
Vulvovaginal	Itching, white "cottage cheese" discharge; common in women
Candidemia	Fever unresponsive to antibiotics in at-risk patient; risk of seeding eyes (endophthalmitis), heart (endocarditis), bones, brain
Chronic disseminated (hepatosplenic)	Fever + rising ALP after neutrophil recovery; "bull's eye" lesions on CT liver/spleen

Treatment:

Mucosal: fluconazole or topical nystatin
Candidemia/invasive: Echinocandins (caspofungin, micafungin, anidulafungin) = first line for most; fluconazole for susceptible C. albicans in stable patients
C. krusei = intrinsically resistant to fluconazole; use echinocandin or voriconazole

Aspergillosis (Aspergillus species)

A. fumigatus most common; also A. flavus, A. terreus, A. niger
Ubiquitous mold; inhaled conidia (spores)

Clinical forms:

Form	Host	Features
Allergic Bronchopulmonary Aspergillosis (ABPA)	Atopic asthmatics, CF	Type I + III hypersensitivity; wheezing, mucus plugs, central bronchiectasis; elevated total IgE, Aspergillus-specific IgE, eosinophilia
Aspergilloma ("fungus ball")	Pre-existing lung cavities (TB, sarcoidosis)	Asymptomatic or hemoptysis; "Monod sign" (mass with air crescent) on CXR/CT; no treatment needed unless hemoptysis
Invasive Pulmonary Aspergillosis (IPA)	Prolonged neutropenia, HSCT, solid organ transplant, high-dose steroids	Fever, cough, pleuritic chest pain; CT: "halo sign" (ground-glass halo around nodule); angioinvasion → infarcts; progresses to "air crescent sign" as patient recovers
Chronic Pulmonary Aspergillosis (CPA)	Structural lung disease (COPD, TB, sarcoidosis), mild immunosuppression	Progressive cavitation, weight loss, hemoptysis

Diagnosis:

CT: halo sign (early), air crescent sign (later recovery phase)
Serum galactomannan assay (β-1,3-glucan also helpful)
BAL galactomannan
Culture (low sensitivity)

Treatment:

ABPA: systemic corticosteroids + itraconazole
Aspergilloma: observation unless hemoptysis; surgery/bronchial artery embolization for massive hemoptysis
IPA: Voriconazole = first line; isavuconazole as alternative; liposomal amphotericin B
A. terreus: resistant to amphotericin B

Cryptococcosis (Cryptococcus neoformans / C. gattii)

Encapsulated yeast
C. neoformans: soil enriched with pigeon droppings; worldwide; mainly in immunocompromised
C. gattii: associated with eucalyptus trees; can affect immunocompetent hosts

Most important manifestation: Cryptococcal Meningoencephalitis

Most common cause of fungal meningitis; major AIDS-defining illness (CD4+ <100 cells/μL)
Subacute/chronic course: headache, fever, altered mental status, visual changes
⚠️ Cryptococcal meningitis has minimal CSF inflammation - may have nearly normal WBC count
India ink stain of CSF: encapsulated yeast with clear halo (positive in ~50-80%)
Cryptococcal antigen (CrAg): serum and CSF; very sensitive and specific

Treatment:

Induction: Amphotericin B (liposomal) + flucytosine (5-FC) x 2 weeks
Consolidation: Fluconazole 400 mg/d x 8 weeks
Maintenance: Fluconazole 200 mg/d (until immune reconstitution on ART)
ICP management: Serial lumbar punctures to relieve elevated intracranial pressure (corticosteroids NOT recommended routinely)

Mucormycosis (Zygomycosis)

Caused by: Mucor, Rhizopus, Lichtheimia (Absidia), Cunninghamella
Angioinvasive - invades blood vessel walls → thrombosis → tissue infarction

Risk factors: Diabetic ketoacidosis (DKA), neutropenia, iron overload, deferoxamine therapy, organ transplant

Forms:

Rhinocerebral: Starts in sinuses → extends to orbit (proptosis, ophthalmoplegia) → brain; classic in DKA; black necrotic eschar on palate/nasal mucosa
Pulmonary: Neutropenic patients; cavitary lesions; halo sign (similar to Aspergillus)
Cutaneous: Trauma, burns
Disseminated: Severe immunosuppression

Diagnosis: Biopsy showing broad, non-septate (pauciseptate), ribbon-like hyphae with right-angle branching (vs Aspergillus = narrow, septate, 45° angle branching)

Treatment:

Liposomal amphotericin B (first line; highest doses tolerated)
Surgical debridement (critical!)
Control underlying condition (correct DKA, reduce immunosuppression)
Isavuconazole or posaconazole as step-down or salvage
⚠️ Voriconazole has NO activity against Mucor

Coccidioidomycosis (Coccidioides immitis / C. posadasii)

Geographic: American Southwest (Arizona, California), northern Mexico, parts of Central/South America ("Valley Fever")
In soil; inhaled spores (arthroconidia)

Forms:

Asymptomatic (60%)
Acute pulmonary: "Valley fever" - flu-like with cough; may have erythema nodosum or erythema multiforme (immune reaction, better prognosis)
Disseminated: Meningitis, skin, bone, joints; more common in immunocompromised, pregnant women, dark-skinned individuals

Diagnosis: Serology (IgM = acute; IgG = chronic/disseminated); culture; complement fixation titers track disease activity

Treatment:

Mild: fluconazole or itraconazole
Severe/disseminated: amphotericin B then azole step-down
Meningitis: Fluconazole (lifelong suppression usually needed)

Antifungal Drug Classes - Summary Table

Class	Drugs	Mechanism	Uses
Polyenes	Amphotericin B (deoxycholate, liposomal), Nystatin	Binds ergosterol → membrane pores → cell death	Broad spectrum; first line for severe fungal infections
Azoles	Fluconazole, Itraconazole, Voriconazole, Posaconazole, Isavuconazole	Inhibit 14α-lanosterol demethylase → block ergosterol synthesis	Very broad; most common oral agents
Echinocandins	Caspofungin, Micafungin, Anidulafungin	Inhibit β-1,3-D-glucan synthase → cell wall synthesis inhibition	Candida (first line invasive), Aspergillus (salvage); NO activity against Cryptococcus
Flucytosine (5-FC)	Flucytosine	Converted to 5-fluorouracil → inhibits DNA/RNA synthesis	Cryptococcal meningitis (always combine - rapid resistance alone)
Allylamines	Terbinafine	Inhibit squalene epoxidase	Dermatophytes (nail/skin fungal infections)

Quick Reference: Diagnosis Mnemonics

Fungi + Geographic clues:

Ohio/Mississippi River valleys → Histoplasma
American Southwest desert → Coccidioides (Valley Fever)
Bird/bat droppings → Histoplasma
Pigeon droppings → Cryptococcus
DKA + black nasal eschar → Mucormycosis

Microscopy clues:

India ink CSF → Cryptococcus
Broad non-septate hyphae → Mucor/Rhizopus
Narrow septate hyphae at 45° → Aspergillus
Yeast with pseudohyphae → Candida
Spherules containing endospores → Coccidioides (in tissue)

QUICK EXAM SUMMARY CHEAT SHEET

Topic	Key Exam Points
Parasites	Protozoa multiply in host; helminths don't (except Strongyloides/Capillaria). Definitive host = larvae ingested. Intermediate host = ova ingested → severe disease
Malaria	Always consider in any traveler/immigrant from malarious area; P. vivax/ovale need primaquine for liver forms
T. solium	Ingesting larvae → intestinal tapeworm (mild); ingesting OVA → cysticercosis (severe)
Respiratory	3 categories: obstructive, restrictive, vascular. HACEK and Bernoulli effect. (A-a)DO₂ elevated in V/Q mismatch/shunt
Lung Abscess	Right lung > left. Anaerobes from gingival crevices. Putrid smell = diagnostic of anaerobic. Metronidazole alone = NOT effective. Ampicillin-sulbactam first line
Bronchiectasis	Irreversible dilation. "Tram tracks" on CXR. Signet ring on CT. CF = 50% of cases. Vicious cycle hypothesis
Cystic Fibrosis	CFTR = Cl⁻/HCO₃⁻ channel. Sweat Cl⁻ test. F508del = severe. Males 99% infertile. P. aeruginosa dominant respiratory pathogen
Meningococcus	Groups A, B, C, W, X, Y. Hajj → Group W vaccine required. Ceftriaxone = prophylaxis (97% carriage eradication). Rifampin fails 15-20%
Gonorrhea	Ceftriaxone first line (cefixime removed). Rmp antibodies block bactericidal activity. PBP2 (penA) = main resistance. Lemierre's = Fusobacterium + jugular vein
HACEK	Oropharyngeal flora; endocarditis. Aggregatibacter = most common. Ceftriaxone 2g/d = first line (80-90% success). Eikenella = resistant to clindamycin
PCP	TMP-SMX = best prophylaxis. Threshold: >20mg prednisone/30d. Alternatives: dapsone, atovaquone, aerosol pentamidine
Aspergillus	IPA: halo sign early, air crescent later. Voriconazole = first line. ABPA: asthma + CF + central bronchiectasis + elevated IgE
Cryptococcus	India ink. CrAg test. Ampho B + 5-FC induction → fluconazole consolidation/maintenance. Minimal CSF inflammation
Mucormycosis	DKA + black eschar. Broad non-septate hyphae. Liposomal ampho B + surgery. Voriconazole = NO activity

Source: Harrison's Principles of Internal Medicine, 22nd Edition (Chapters 228, 229, 160, 161, 163, 295, 296) and DMSF Department of Internal Medicine lecture slides (Dr. M. Platero, RN, MD, FPCP) on Lung Abscess, Bronchiectasis, and Cystic Fibrosis.

Good luck on your exam! If you want me to go deeper on any single topic, quiz you with questions, or create flashcards, just ask. You can reply with "continue" to resume with a fresh budget if you need more content (such as the full dedicated Fungal Infections chapter from Harrison's if you have it uploaded, or detailed drug dosing tables).

Create high-yield clinical case scenarios (10-15) for each topic to test understanding

Here are 10-15 high-yield clinical case scenarios per topic - each written in exam format with a stem, options, answer, and teaching point.

🩺 HIGH-YIELD CLINICAL CASE SCENARIOS

3rd Year Internal Medicine Exam Practice

TOPIC 1: PARASITIC INFECTIONS

15 Cases

Case 1 A 28-year-old Filipino man returns from a 3-week humanitarian mission in sub-Saharan Africa. Two weeks after returning, he develops high-grade fever, chills, and headache. Blood smear shows ring-form trophozoites within red blood cells, with multiple infected cells and some containing more than one ring form per RBC.

Q: What is the MOST likely diagnosis and the MOST feared complication?

Answer: Plasmodium falciparum malaria. Most feared complication: cerebral malaria (coma, seizures). P. falciparum uniquely causes multiple ring forms per RBC, infected erythrocyte sequestration in cerebral microvasculature, and rapid progression to severe disease. Unlike P. vivax/P. ovale, it has no persistent liver forms (hypnozoites) so primaquine is NOT required.

Case 2 A 35-year-old woman from New England presents with fever, fatigue, and hemolytic anemia 2 weeks after tick exposure. She had a splenectomy 2 years ago. Blood smear shows "Maltese cross" (tetrad) forms within RBCs.

Q: What organism is responsible, and why is this patient at higher risk?

Answer: Babesia microti (babesiosis). The "Maltese cross" or tetrad form is pathognomonic. Her splenectomy significantly increases the risk of severe infection because the spleen is a major site for clearing parasitized RBCs. Babesia is transmitted by Ixodes scapularis ticks in the northeastern and midwestern USA.

Case 3 A 24-year-old medical student eats undercooked pork sausage at a rural festival. Three weeks later she develops periorbital (palpebral) edema, severe myalgias, and fever. CBC shows WBC 12,000 with 40% eosinophils.

Q: What is the diagnosis and the diagnostic test of choice?

Answer: Trichinellosis (Trichinella spiralis). Classic triad: periorbital/palpebral edema + myalgias + high-level eosinophilia. Source: undercooked pork. Diagnosis: serology (anti-Trichinella antibodies); muscle biopsy shows larvae in skeletal tissue. Treatment: albendazole.

Case 4 A 32-year-old man with HIV (CD4 count 45 cells/μL) develops progressive bilateral perihilar infiltrates on CXR, dry cough, and exertional dyspnea for 3 weeks. PaO₂ is 58 mmHg on room air. He is not on any prophylaxis.

Q: What is the diagnosis and the appropriate treatment regimen?

Answer: Pneumocystis jirovecii Pneumonia (PCP). Bilateral perihilar infiltrates + dry cough + subacute onset in profoundly immunocompromised (CD4 <200) patient not on TMP-SMX prophylaxis is classic. Treatment: high-dose TMP-SMX (15-20 mg/kg/day of TMP component in divided doses x 21 days) PLUS adjunctive prednisone because PaO₂ <70 mmHg (A-a gradient >35). Prednisone prevents inflammatory worsening when organisms die.

Case 5 A 40-year-old man from rural Mexico presents with seizures. MRI brain shows multiple ring-enhancing lesions with surrounding edema. He recalls eating from street vendors frequently. Serology for cysticercosis is positive.

Q: What is the life cycle step that caused this infection, and how does treatment differ from intestinal tapeworm infection?

Answer: Neurocysticercosis from Taenia solium. He ingested OVA (from contaminated food/water/feces of a T. solium carrier) → humans acted as intermediate host → larvae migrated to brain. This is the severe form. If he had eaten undercooked pork containing larvae, he would have had intestinal tapeworm infection (mild). Treatment: albendazole + dexamethasone (steroids prevent inflammatory response as cysts die) + anticonvulsants. Note: dexamethasone also increases albendazole sulfoxide levels ~50%.

Case 6 A 19-year-old college student from the Philippines recently ate raw freshwater snails. Three weeks later she develops eosinophilic meningitis with CSF showing 30% eosinophils. She is from a Southeast Asian coastal community.

Q: What is the MOST likely causative parasite?

Answer: Angiostrongylus cantonensis - the most common parasitic cause of eosinophilic meningitis. Larvae are ingested from raw snails/slugs or contaminated vegetables, penetrate the intestine, migrate to the brain and meninges where they die and attract massive eosinophilic infiltration. Most patients recover spontaneously. Endemic in Southeast Asia and Pacific Islands.

Case 7 A 26-year-old Peace Corps volunteer in West Africa receives a tsetse fly bite. Two weeks later he develops a painful ulcer (chancre) at the bite site, followed by fever, lymphadenopathy, and weight loss. His lymph nodes are markedly enlarged, particularly posterior cervical nodes ("Winterbottom's sign").

Q: What organism and what will eventually happen without treatment?

Answer: Trypanosoma brucei gambiense (West African sleeping sickness). Early stage: chancre, fever, adenopathy, cyclical fevers. Late stage (months-years): CNS involvement → disrupted sleep-wake cycle (sleeping sickness), altered behavior, coma, death. T.b. gambiense has late CNS involvement (vs T.b. rhodesiense which causes rapid early CNS involvement). Treatment: suramin or pentamidine for early stage; melarsoprol or eflornithine for late stage.

Case 8 A 55-year-old man from Egypt presents with hematuria, dysuria, and recurrent UTIs for several years. Cystoscopy reveals a thickened, granular bladder wall. He was a farmer who waded in irrigation canals.

Q: What is the organism, and what is the long-term cancer risk?

Answer: Schistosoma haematobium infection. The organism's eggs deposit in the veins of the ureter and bladder, causing granuloma formation, fibrosis, and obstructive uropathy. Key: S. haematobium is associated with increased risk of squamous cell carcinoma of the bladder (due to chronic inflammation). S. mansoni/S. japonicum target mesenteric vessels → portal hypertension and cirrhosis. Treatment: praziquantel.

Case 9 A 38-year-old HIV-positive man (CD4 120 cells/μL) from Brazil develops fever, heart palpitations, and progressive dysphagia for solids and liquids. ECG shows right bundle branch block. Echo reveals dilated cardiomyopathy.

Q: What is the diagnosis and how was it likely acquired?

Answer: Chagas disease (Trypanosoma cruzi) with cardiac and esophageal (megaesophagus) involvement. Transmitted by reduviid (kissing) bugs - the bug defecates during a blood meal and the patient scratches the bite, rubbing feces (containing trypanosomes) into the wound. Initial parasitemia is often asymptomatic; years later → megaesophagus + dilated cardiomyopathy. Note: T. cruzi is an AIDS-defining illness and can reactivate with HIV. Treatment: benznidazole or nifurtimox (most effective in acute phase).

Case 10 A 30-year-old woman presents with bloody diarrhea and cramping for 5 days. Stool microscopy shows trophozoites with ingested red blood cells. She returned from India 2 weeks ago.

Q: What is the organism, and what is the critical diagnostic challenge?

Answer: Entamoeba histolytica (amebiasis). The only intestinal protozoan causing invasive disease. Critical challenge: The cysts and trophozoites of E. histolytica are morphologically identical to E. dispar (non-invasive, more common globally). Cannot distinguish by microscopy alone - requires PCR, ELISA antigen testing, or isoenzyme analysis. Treatment: metronidazole (tissue amebicide) followed by diloxanide furoate or paromomycin (luminal amebicide) to eliminate intestinal cysts.

Case 11 A physician prescribes metronidazole alone to treat a patient with E. histolytica liver abscess. The patient improves clinically but 6 weeks later has a relapse of intestinal symptoms.

Q: What was the management error?

Answer: Metronidazole is a tissue amebicide only - it kills trophozoites in tissue but does NOT eliminate intestinal luminal cysts. After treating invasive disease with metronidazole, a luminal amebicide (diloxanide furoate OR paromomycin OR iodoquinol) MUST be added to eliminate the intestinal reservoir and prevent relapse/transmission.

Case 12 A 45-year-old fisherman from the Great Lakes region presents with megaloblastic anemia, B12 deficiency, and passage of a long tapeworm segment. He eats raw pickled fish.

Q: What is the causative organism and the mechanism of B12 deficiency?

Answer: Diphyllobothrium latum (fish tapeworm). The worm avidly absorbs vitamin B₁₂ (cobalamin) within the intestinal lumen before the host can absorb it, leading to B12 deficiency and megaloblastic anemia. Acquired by eating undercooked or raw freshwater fish. Treatment: praziquantel.

Case 13 A patient is prescribed dapsone as prophylaxis for PCP after refusing TMP-SMX due to allergy. You review his chart and note a prior life-threatening Stevens-Johnson syndrome from sulfamethoxazole.

Q: Is dapsone appropriate in this patient? Why?

Answer: No. Dapsone cross-reacts with sulfonamides in a substantial fraction of patients and is rarely useful in patients with a history of life-threatening reactions to TMP-SMX (which contains sulfamethoxazole). Appropriate alternatives: atovaquone (effective and well-tolerated, but absorption is unpredictable with GI motility issues) or monthly aerosol pentamidine (less effective; doesn't protect poorly ventilated lung regions).

Case 14 A 22-year-old woman with no underlying illness develops dysentery with bloody diarrhea and high fever (39.5°C) acutely after eating contaminated food at a picnic. She has no travel history. Stool culture is pending.

Q: What features help differentiate this from amebic dysentery?

Answer: The key differentiating features:

Feature	Bacterial (Salmonella/Shigella/Campylobacter)	Amebic (E. histolytica)
Fever	High, acute onset	Lower-grade or absent
Onset	Rapid (hours-days)	Slower (days-weeks)
Travel	Not required	Usually endemic area exposure
History	Food-borne outbreak	Often no clear source
Complications	Bacteremia	Liver abscess, distant spread

Bloody diarrhea with HIGH fever and RAPID onset in a person with no travel history favors bacterial etiology. Amebiasis typically has a slower onset with lower fever.

Case 15 A 50-year-old man with CLL on ibrutinib develops diffuse pulmonary infiltrates and hypoxemia. Bronchoscopy washings show cyst forms that stain with Gomori methenamine silver (GMS). His CD4+ count is 210 cells/μL despite no HIV.

Q: What is the diagnosis and why did this patient get it?

Answer: Pneumocystis jirovecii Pneumonia (PCP) in a non-HIV immunocompromised patient. PCP occurs not just in HIV patients - it also affects patients receiving glucocorticoids (>20 mg prednisone/30 days), ibrutinib (BTK inhibitor), anti-CD20 agents (rituximab), anti-TNF agents, antithymocyte globulin, and alemtuzumab. GMS staining of BAL (or silver staining) shows cyst walls of P. jirovecii. These non-HIV patients can get PCP even without severely low CD4 counts. TMP-SMX prophylaxis should have been initiated.

TOPIC 2: RESPIRATORY PHYSIOLOGY & APPROACH TO RESPIRATORY DISEASE

12 Cases

Case 1 A 55-year-old smoker with known COPD is admitted with worsening dyspnea. He describes "chest tightness and inability to get a deep breath." ABG shows: pH 7.35, PaCO₂ 55 mmHg, PaO₂ 62 mmHg, HCO₃ 30 mEq/L.

Q: What type of respiratory pathophysiology does he have, and what do the ABGs indicate?

Answer: Obstructive lung disease with compensated chronic respiratory acidosis (type II respiratory failure). The elevated PaCO₂ (hypercarbia) with compensatory elevated HCO₃ indicates chronic CO₂ retention - a hallmark of severe obstructive disease where airflow limitation and V/Q mismatch lead to CO₂ accumulation. The description "chest tightness / inability to get a deep breath" is the classic dyspnea quality of obstructive lung disease. "Air hunger/suffocation" characterizes heart failure instead.

Case 2 A 65-year-old woman with congestive heart failure describes her breathlessness as "air hunger" and a "sense of suffocation." She cannot lie flat and wakes up gasping 2 hours after falling asleep.

Q: What are the clinical terms for her symptoms, and how does her dyspnea quality help localize the cause?

Answer: She has orthopnea (inability to lie flat - redistributed fluid from legs to lungs) and paroxysmal nocturnal dyspnea (PND) (waking from sleep with SOB). The quality "air hunger / suffocation" specifically points toward congestive heart failure rather than obstructive lung disease. This distinction in dyspnea quality (Harrison's Chapter 295) is a key differentiating tool in the history before any testing.

Case 3 A 68-year-old man with IPF reports gradually worsening exertional dyspnea over 3 years. He states he now gets short of breath walking from the parking lot to his clinic, but previously could walk several blocks. PFT shows FVC 52% predicted, FEV₁/FVC ratio 0.85.

Q: What category of disease does he have, and why is it important to ask specifically about his level of activity?

Answer: Restrictive lung disease (reduced FVC, preserved FEV₁/FVC ratio >0.70). Important insight from Harrison's Chapter 295: Many patients with progressive disease adapt their activity level to accommodate their limitation. If you only ask "are you short of breath?" he might say "not really" because he has stopped doing activities that cause dyspnea. Asking specifically what activities he can and cannot do reveals the true degree of disability. Always ask: "What activities make you short of breath, and how has this changed?"

Case 4 A 33-year-old woman with allergic asthma reports intermittent episodes of chest tightness and cough. She is fine between episodes. She identifies that her symptoms consistently worsen during spring and when she visits her friend's house (the friend has two cats).

Q: What pattern distinguishes her asthma from COPD or IPF?

Answer: Intermittent episodic dyspnea with specific triggers is the characteristic pattern of asthma. In contrast:

COPD/IPF: Gradual progression of dyspnea on exertion, punctuated by acute exacerbations
Asthma: Most patients do NOT have daily symptoms; experience intermittent episodes triggered by allergens (cats, pollen), URI, exercise, cold air, NSAIDs

This pattern recognition from history alone narrows the differential significantly.

Case 5 A spirometry report shows: FEV₁ = 1.2L (45% predicted), FVC = 2.8L (75% predicted), FEV₁/FVC = 0.43. The flow-volume loop shows a scooped-out concave appearance on the expiratory limb.

Q: What is the pattern, and what diseases cause this?

Answer: Obstructive pattern - FEV₁/FVC <0.70 (here 0.43 = severe obstruction). The "scooped out" concave expiratory limb on flow-volume loop is due to the Bernoulli effect causing early airway collapse during forced expiration at lower lung volumes (dynamic airflow limitation). Causes: COPD/emphysema, asthma, bronchiectasis, obliterative bronchiolitis. In emphysema specifically: reduced lung elastic recoil → maximal expiratory flow falls (reduced lung recoil is the principal mechanism per Harrison's Chapter 296).

Case 6 A 60-year-old man with COPD is being evaluated. Spirometry shows FEV₁/FVC = 0.58. His ABG shows increased (A-a)DO₂ of 38 mmHg (normal <15 mmHg). His PaCO₂ is normal.

Q: What does the elevated (A-a)DO₂ indicate about the mechanism of his hypoxemia?

Answer: Elevated (A-a)DO₂ indicates V/Q mismatch or intrapulmonary shunt as the mechanism of hypoxemia - not hypoventilation alone (pure hypoventilation would give a normal (A-a)DO₂). In COPD, airways obstruction → uneven ventilation distribution → some alveoli are ventilated but underperfused (dead space) and others are perfused but underventilated (shunt-like physiology) → V/Q mismatch. This is the classic mechanism of hypoxemia in obstructive lung disease. Normal PaCO₂ here means the patient is compensating for hypoxemia by hyperventilating.

Case 7 A 45-year-old former asbestos worker presents with progressive dyspnea on exertion over 2 years. PFT: TLC 68% predicted, FVC 60% predicted, FEV₁/FVC 0.82, DLCO 45% predicted. CXR shows bilateral lower lobe reticular opacities and pleural plaques.

Q: What pattern of disease does this represent, and what does each PFT finding tell you?

Answer: Restrictive lung disease (reduced TLC confirms restriction; FEV₁/FVC preserved >0.70 rules out obstruction). The markedly reduced DLCO (diffusing capacity) indicates impaired gas exchange across the alveolar-capillary membrane - consistent with interstitial fibrosis (asbestosis). In fibrosis, lung recoil pressure is INCREASED at any given volume (Harrison's Chapter 296) → maximal expiratory flow is elevated relative to lung volume (the flow-volume loop may look "tall and narrow"). Pleural plaques are the radiographic hallmark of asbestos exposure.

Case 8 A 28-year-old man develops sudden-onset sharp pleuritic chest pain and dyspnea while playing basketball. On exam, the left hemithorax has absent breath sounds and the trachea is deviated to the right. His oxygen saturation is 88%.

Q: What is the diagnosis and what would ABG show?

Answer: Left-sided tension pneumothorax (absent breath sounds + tracheal deviation away from affected side = tension). This is an acute dyspnea etiology - "sudden physiologic changes" causing acute shortness of breath (Harrison's Chapter 295). ABG would show acute hypoxemia with increased (A-a)DO₂ (collapsed lung creates a large shunt - blood flows through unventilated lung). Immediate management: needle decompression at 2nd intercostal space, midclavicular line → followed by chest tube.

Case 9 A physician examines a patient with COPD. Despite the patient breathing normally, auscultation of the chest reveals diffusely diminished breath sounds throughout both lung fields without any focal area of absence.

Q: Why are breath sounds diminished in COPD?

Answer: In emphysema (a subtype of COPD), destruction of alveolar walls → lung hyperinflation → increased air trapping → increased distance between lung parenchyma and chest wall stethoscope → poor transmission of sound → globally diminished/quiet breath sounds. This is distinct from a focal absence of breath sounds (which suggests pleural effusion, pneumothorax, or lobar consolidation). The quiet, barrel-chested patient is the classic emphysema presentation.

Case 10 A 50-year-old woman with idiopathic pulmonary fibrosis (IPF) is admitted with worsening dyspnea. Her ABG shows PaO₂ 58 mmHg. The resident orders only a plain CXR which shows subtle bilateral haziness.

Q: What additional imaging should be done, and what would it likely show?

Answer: CT scan of the chest (high-resolution HRCT) should be obtained. Plain CXR has limited sensitivity for parenchymal processes like IPF. HRCT would show the classic usual interstitial pneumonia (UIP) pattern: bilateral, peripheral, basal-predominant honeycombing with or without traction bronchiectasis, and subpleural reticular opacities. Harrison's Chapter 295 emphasizes that CT: "can delineate parenchymal processes, pleural disease, masses or nodules, and large airways" with much greater detail than CXR. An ultrasound could confirm pleural effusion if suspected but would not characterize the parenchyma.

Case 11 A patient attempts to exhale as forcefully as possible with a spirometer. Despite increasing effort, the expiratory flow beyond a certain point does not increase.

Q: What physiologic principle explains this, and what is the clinical term?

Answer: Dynamic airflow limitation - explained by the Bernoulli effect. During forced expiration, gas accelerates toward the mouth → pressure drops → transmural airway pressure decreases → airways narrow. If expiratory effort increases beyond the flow limit, local velocity increases further → airways narrow even more → net flow does not increase. This is called flow limitation or reaching the maximum expiratory flow (effort-independent flow). This is why spirometry beyond a certain effort level does not help - maximum expiratory flow at any lung volume is effort-independent under normal conditions (Harrison's Chapter 296).

Case 12 A 36-year-old woman undergoes evaluation for progressive dyspnea. CXR is completely normal. PFT shows: FEV₁/FVC = 0.68, FVC = 85% predicted, FEV₁ = 58% predicted. Spirometry post-bronchodilator shows FEV₁ improves by 15% and 250 mL.

Q: What is the diagnosis, and what does the CXR finding (or lack thereof) teach us?

Answer: Asthma (obstructive pattern with significant bronchodilator reversibility ≥12% and ≥200 mL). Critical teaching point from Harrison's Chapter 295: "Many diseases of the respiratory system, particularly those of the airways and pulmonary vasculature, are associated with a normal chest radiograph." Asthma, early COPD, pulmonary hypertension, and pulmonary embolism can all have a completely normal CXR despite significant pathology. A normal CXR does NOT exclude significant respiratory disease.

TOPIC 3: BRONCHIECTASIS, LUNG ABSCESS, CYSTIC FIBROSIS

15 Cases

Case 1 A 42-year-old non-smoker woman presents with daily productive cough for 3 years, producing 1-2 cups of thick purulent sputum per day. She has had 4 pneumonias in the past 5 years. CXR shows increased markings in both lower lobes with "tram-track" opacities. Chest CT shows bilateral lower lobe dilation of airways.

Q: What is the diagnosis and what CT finding confirms it?

Answer: Bronchiectasis. The "tram-track" sign on CXR represents thickened, dilated airway walls seen end-on. On CT, the diagnostic finding is the "signet ring sign" - an enlarged airway (the ring) sitting adjacent to a normal-sized pulmonary artery (the signet stone). CT is the imaging modality of choice for confirming bronchiectasis. The bilateral lower lobe distribution suggests chronic recurrent aspiration or hypogammaglobulinemia as the underlying cause.

Case 2 A 19-year-old male was hospitalized 3 times for Bordetella pertussis pneumonia between ages 2-5. Now at age 19 he has persistent productive cough, clubbing of his fingers, and crackles on exam. PFT shows mild airflow obstruction.

Q: How did his childhood infections cause his current condition?

Answer: Post-infectious bronchiectasis from childhood B. pertussis (whooping cough) infections. The vicious cycle hypothesis: his impaired mucociliary clearance (possibly from pertussis toxin damaging cilia) + repeated severe infections → inflammatory damage to airway walls → dilation + loss of elastic tissue, smooth muscle, and cartilage → irreversible bronchiectasis. Digital clubbing results from chronic hypoxemia and chronic suppurative lung disease. His PFT shows mild airflow obstruction which is typical of bronchiectasis (not the normal expected finding of normal or restrictive).

Case 3 A 68-year-old man with alpha-1 antitrypsin deficiency develops progressive dyspnea and productive cough. CT shows both basilar emphysema AND bronchiectasis.

Q: What is the common mechanism linking these two findings in alpha-1 antitrypsin deficiency?

Answer: Alpha-1 antitrypsin (AAT) normally neutralizes neutrophil elastase, protecting airway walls and alveolar tissue from proteolytic damage. Without AAT:

Neutrophil elastase destroys alveolar walls → emphysema
Neutrophil elastase also destroys bronchial walls (elastic tissue, smooth muscle, cartilage) → bronchiectasis
Additionally impairs bacterial killing

So AAT deficiency classically causes both emphysema AND bronchiectasis through unchecked protease activity. Bronchiectasis from AAT deficiency tends to be in the lower lung fields (as noted in the slides - lower lung = fibrotic/end-stage, but AAT also affects lower zones where blood flow is higher and inflammation is greater).

Case 4 A 50-year-old man with bronchiectasis develops sudden massive hemoptysis (>300 mL in one episode). He is actively coughing up bright red blood.

Q: What is the immediate management priority and what is the definitive treatment?

Answer: Immediate priority (from Dr. Platero's slides):

Intubate to stabilize the patient (protect airway)
Identify source of bleeding (bronchoscopy)
Protect the non-bleeding lung (position with bleeding side DOWN, or selective intubation of non-bleeding bronchus)
Control of bleeding:
- First: Bronchial artery embolization (BAE) - preferred initial approach
- Surgery: reserved for severe/refractory cases

The bleeding source in bronchiectasis is usually the bronchial arteries (high-pressure systemic circulation), not pulmonary arteries, which is why embolization is effective.

Case 5 An alcoholic 56-year-old man is brought in obtunded after a witnessed aspiration episode. Three weeks later, CXR shows a right-sided cavitary lesion with an air-fluid level in the posterior upper lobe. Sputum is foul-smelling.

Q: What is the diagnosis, what is the causative organism type, and why is the lesion on the RIGHT side in the posterior upper lobe?

Answer: Primary lung abscess (anaerobic). Three key teaching points:

Organism: Anaerobic bacteria from oral gingival crevices (foul smell = "putrid" lung abscess = essentially diagnostic of anaerobic infection)
Location - right side: Right main bronchus is less angulated than the left → aspirated material preferentially goes to the right lung
Location - posterior upper lobe: This is a dependent segment - when aspiration occurs lying down (alcoholic stupor), gravity draws material to the posterior upper lobes. Other dependent segments: superior lower lobes. The right posterior upper lobe + right superior lower lobe are the classic locations for aspiration pneumonia/abscess.

Case 6 A 60-year-old woman with lung cancer presents with a new cavitary right lower lobe lesion. She is started on ampicillin-sulbactam for presumed lung abscess.

Q: What is the classification of this abscess, and what additional step is critical before assuming it is purely infectious?

Answer: This is a secondary lung abscess - caused by post-obstructive bronchial obstruction from the lung tumor. Critical additional step: bronchoscopy with biopsy and CT-guided needle aspiration to rule out underlying malignancy and obtain culture material. Per Dr. Platero's slides: patients with risk factors for malignancy (smokers, >45 years, known malignancy) OR immunocompromised patients OR those with atypical presentations should undergo early invasive diagnostics rather than empiric treatment alone. Always rule out TB in endemic areas or HIV patients.

Case 7 A resident prescribes metronidazole alone for a patient with a putrid primary lung abscess. The attending immediately corrects this.

Q: Why is metronidazole alone not appropriate?

Answer: Per Dr. Platero's slides: "Metronidazole is NOT effective as a single agent" for lung abscess. Reasons:

Lung abscesses are typically polymicrobial (anaerobes + microaerophilic streptococci)
Metronidazole covers anaerobes well but misses microaerophilic organisms and facultative bacteria
Multiple studies show clinical failure with metronidazole monotherapy

Correct treatment: IV beta-lactam/beta-lactamase inhibitor combination (ampicillin-sulbactam) then oral amoxicillin-clavulanate, OR moxifloxacin 400 mg/d PO (as effective as ampicillin-sulbactam). Duration: 3-14 weeks until imaging shows clearance.

Case 8 A 48-year-old IV drug user with tricuspid valve endocarditis (S. aureus) develops multiple bilateral pulmonary nodules that then cavitate.

Q: What is the mechanism of his lung abscesses, and how does this differ from typical aspiration abscess?

Answer: Septic pulmonary emboli from tricuspid valve endocarditis. The mechanism:

Infected vegetations on the tricuspid valve → fragments break off → travel through right heart → lodge in pulmonary arteries → cause septic infarcts → cavitate → multiple bilateral abscesses

This differs from aspiration abscess in:

Location: Bilateral and scattered vs. single dependent-segment lesion
Number: Multiple vs. typically single
Cause: Hematogenous seeding vs. direct aspiration
Microbiology: S. aureus (aerobic, non-anaerobic) vs. polymicrobial anaerobes

Also recall Lemierre's syndrome: Fusobacterium necrophorum pharyngeal infection → spreads to carotid sheath containing jugular vein → septic thrombophlebitis of jugular vein → septic emboli to lungs.

Case 9 A 14-year-old boy with known CF develops acute worsening of his chronic cough with increased sputum volume and purulence, mild temperature elevation, and decreased FEV₁. Sputum culture grows Pseudomonas aeruginosa.

Q: What is the mechanism by which CF predisposes to P. aeruginosa infection?

Answer: Step-by-step (from Dr. Platero's slides):

CFTR mutation → Cl⁻/HCO₃⁻ channel dysfunction
Depleted periciliary fluid layer (PCL) → ciliary collapse → failure to clear overlying mucus
Abnormal airway surface fluid composition (e.g., pH) → impaired innate bacterial killing
Thick, hyperviscous mucus → ideal biofilm environment for P. aeruginosa
P. aeruginosa propensity to colonize damaged airways + form biofilms + evade host defenses
Chronic infection → intense neutrophilic inflammation + protease release + oxidants → airway remodeling → bronchiectasis

This is an acute CF pulmonary exacerbation - treat with inhaled tobramycin or IV anti-pseudomonal antibiotics.

Case 10 A 2-day-old neonate fails to pass meconium after birth. Abdominal X-ray shows dilated loops of bowel. The mother reports a family history of early deaths in siblings with lung disease.

Q: What is the diagnosis, what genetic test confirms it, and what is the pathogenesis in the bowel?

Answer: Cystic fibrosis presenting as meconium ileus. In CF:

CFTR dysfunction → failure of Cl⁻/HCO₃⁻ secretion into intestinal lumen → inadequate hydration of meconium → abnormally thick, tenacious meconium → obstructs the terminal ileum (meconium ileus)

Confirmation: CFTR mutation analysis (sweat chloride test unreliable in first days of life - sweat test best at 4+ weeks). Newborn screening programs detect elevated immunoreactive trypsinogen (IRT) as first screen, then confirmatory CFTR gene sequencing and/or sweat chloride.

In adults with CF: same mechanism → distal intestinal obstructive syndrome (DIOS) (equivalent of meconium ileus in older patients).

Case 11 A 25-year-old CF male tells his doctor he and his wife have been trying to conceive for 2 years without success. His wife has had a normal fertility workup. He reports no difficulty with sexual function.

Q: What is the specific reproductive defect in males with CF, and is his spermatogenesis affected?

Answer: Complete involution (bilateral absence) of the vas deferens (CBAVD) - the vas deferens does not develop properly because CFTR is required for its development. This causes obstructive azoospermia (sperm are produced but cannot be delivered). Spermatogenesis is INTACT - approximately 99% of males with CF are infertile but they still produce normal sperm in the testes. This means assisted reproductive techniques (ART) using testicular sperm extraction (TESE) + IVF/ICSI can allow biological fatherhood. Females with CF also have reduced fertility due to abnormal cervical mucus and reproductive tract anomalies.

Case 12 A CF patient's sweat chloride comes back at 68 mEq/L (normal <30, borderline 30-59, positive ≥60). His brother's result is 22 mEq/L.

Q: What does the elevated sweat chloride indicate mechanistically?

Answer: Confirmed CF diagnosis. Mechanism:

Normal sweat gland duct: reabsorbs chloride from primary sweat secretion → low final sweat Cl⁻
CF (CFTR malfunction): diminished chloride reabsorption from sweat duct lumen → markedly elevated Cl⁻ in sweat

This is the pathophysiologic basis of the sweat test - highly specific for CF. The respiratory mucosa has the opposite problem (depleted secretion) but in sweat ducts the CFTR defect means it cannot reabsorb Cl⁻. Note: F508del, G551D, and truncation alleles are "severe" mutations → pancreatic insufficiency; they are poor predictors of respiratory prognosis.

Case 13 A 16-year-old CF girl on ivacaftor-tezacaftor-elexacaftor (Trikafta) has had dramatic improvement in FEV₁ from 55% to 80% predicted over 12 months.

Q: What is the mechanism of action of CFTR modulators vs. traditional CF management?

Answer: Traditional CF management treats the consequences of CFTR dysfunction (bronchial hygiene, antibiotics, enzymes). CFTR modulators target the defective CFTR protein itself:

Ivacaftor (potentiator): Opens/gates CFTR channels that reach the cell surface but don't function properly (e.g., G551D mutation - gating defect)
Tezacaftor + Elexacaftor (correctors): Help misfolded CFTR protein (F508del) traffic correctly to the cell surface
Combined Trikafta (elexacaftor-tezacaftor-ivacaftor): Works for F508del (most common mutation, ~90% of CF patients) - doubles the amount of CFTR reaching the membrane AND makes it function better

This represents a true disease-modifying treatment, not just symptom management.

Case 14 A 35-year-old man is found to have dilated airways on CT predominantly in the central airways with mucus plugging. He has asthma, peripheral eosinophilia of 900 cells/μL, elevated total IgE >1000 IU/mL, and positive Aspergillus precipitins.

Q: What is the diagnosis and what category of bronchiectasis etiology does it represent?

Answer: Allergic Bronchopulmonary Aspergillosis (ABPA) - causing central bronchiectasis. Per the etiology table from Dr. Platero's slides, central airway bronchiectasis suggests ABPA or congenital causes. ABPA represents noninfectious bronchiectasis from immune-mediated reactions (Type I IgE-mediated + Type III immune complex-mediated hypersensitivity) to Aspergillus antigens that damage bronchial walls. Diagnostic criteria include: asthma or CF + elevated total IgE + Aspergillus-specific IgE + central bronchiectasis + eosinophilia. Treatment: oral corticosteroids + itraconazole.

Case 15 A patient with primary lung abscess is treated with IV ampicillin-sulbactam. After 5 days he still has fever (38.8°C). The family demands to know why he is not improving.

Q: How do you counsel the family?

Answer: Per Dr. Platero's slides: "Defervescence may take as long as 7 days even with appropriate therapy." This is a key clinical teaching point - lung abscess responds slowly to antibiotics. The family should be reassured that:

Slow defervescence is expected and does NOT indicate treatment failure in the first 5-7 days
Serial imaging at 2-4 weeks is used to assess response
10-20% of patients may not respond (continuing fever + increasing abscess size) - if so, additional studies are needed to rule out underlying predisposing cause
Abscesses >6-8 cm in diameter are less likely to respond to antibiotics alone and may need percutaneous drainage or surgery

TOPIC 4: GRAM-NEGATIVE INFECTIONS - MENINGOCOCCAL, GONOCOCCAL, HACEK

14 Cases

Case 1 A 19-year-old freshman college student develops sudden-onset severe headache, fever of 39.8°C, and neck stiffness. Within 6 hours he develops a non-blanching petechial rash spreading rapidly to purpura on his trunk and legs. He lives in a dormitory.

Q: What is the diagnosis, most likely serogroup, and what IMMEDIATE action is needed?

Answer: Meningococcal septicemia with meningitis (Neisseria meningitidis). Most likely serogroup in dormitory clusters: Group C or Group W (sequence type 11 clone - strongly associated with clusters in closed communities including colleges, universities, military training centers). The non-blanching petechial/purpuric rash is pathognomonic of meningococcemia. Immediate actions:

IV ceftriaxone IMMEDIATELY (do not wait for lumbar puncture if patient is hemodynamically unstable)
ICU admission (mortality 25-40% in fulminant septicemia)
Meningococcal prophylaxis for intimate/household contacts + healthcare workers exposed to respiratory secretions

Case 2 A 2-year-old child presents with fever and irritability. The parents report she is not acting normally and is inconsolable. There is no neck stiffness or photophobia. On exam, there is a bulging anterior fontanelle.

Q: Why might classic meningitis signs be absent, and what is the significance of the fontanelle finding?

Answer: Per Harrison's Chapter 160: "Classic signs of meningitis, such as neck stiffness and photophobia, are often absent in infants and young children with bacterial meningitis." Young children typically present with fever, irritability, and a bulging fontanelle (the fontanelle is the "pressure valve" that bulges when intracranial pressure rises). Neck stiffness requires a degree of cognitive cooperation that infants cannot provide. A bulging fontanelle = raised intracranial pressure = medical emergency. This child needs immediate blood cultures + LP (unless signs of herniation) + empiric antibiotics.

Case 3 A 20-year-old Saudi Arabia pilgrim returning from the Hajj develops fever, neck stiffness, and headache. LP shows gram-negative diplococci.

Q: What serogroup is most likely, and what public health measure now addresses this?

Answer: Serogroup W meningococcus (N. meningitidis group W, formerly W135). The Hajj pilgrimage in 2000/2001 caused major outbreaks of Group W meningococcal disease, leading to the international requirement that pilgrims traveling to Saudi Arabia must receive meningococcal vaccination (MenACWY conjugate) prior to travel. This is a mandatory travel health requirement and a major public health intervention that directly emerged from these outbreaks (Harrison's Chapter 160).

Case 4 Close contacts of a confirmed meningococcal disease case are being managed. The index patient was treated with penicillin G. Contact #1 is pregnant. Contact #2 is a 15-year-old. The health department recommends prophylaxis.

Q: What prophylactic agent is safest for the pregnant contact, and what are the options for the teenager?

Answer:

Pregnant contact: Ceftriaxone (single IM injection) - 97% effective in carriage eradication; safe in all ages and in pregnancy
15-year-old: Ceftriaxone OR ciprofloxacin (if fluoroquinolone resistance not an issue) - fluoroquinolones CAN be used in adolescents for prophylaxis; NOT recommended for treatment of active infection in <18 years old

Key point: Rifampin is NOT optimal because it fails in 15-20% of cases, requires 4 doses (compliance), and resistance is emerging. If the index patient was treated with penicillin (which does NOT reliably clear nasopharyngeal carriage), the index patient themselves should also receive a prophylactic agent at the end of treatment.

Case 5 A 22-year-old man presents with dysuria and urethral discharge for 4 days. Gram stain of the discharge shows gram-negative diplococci within neutrophils (intracellular). Culture confirms Neisseria gonorrhoeae. His last sexual contact was 1 week ago.

Q: What is the first-line treatment, and what co-infection must you always treat simultaneously?

Answer: First-line treatment:

Ceftriaxone 500 mg IM (single dose) - first-line for uncomplicated urogenital gonorrhea

Must ALWAYS simultaneously treat for Chlamydia trachomatis co-infection (frequently co-existing, cannot be excluded without testing):

Doxycycline 100 mg PO BID x 7 days (if chlamydia not ruled out)

Also notify and treat sexual partners. Cefixime (oral) has been removed from first-line recommendations because of rising MICs and insufficient drug levels in pharyngeal tissue. Note: All patients should be tested for HIV, syphilis, and other STIs at the same visit.

Case 6 A 28-year-old sexually active woman develops fever, right upper quadrant pain, and cervical motion tenderness. She has a prior gonococcal infection. Liver enzymes show elevated ALT/AST. Ultrasound shows a normal gallbladder and liver with a small amount of free fluid around the liver.

Q: What is the diagnosis and what is its full name?

Answer: Fitz-Hugh-Curtis syndrome (perihepatitis) - a complication of ascending gonococcal (or chlamydial) infection. The organism spreads from the fallopian tubes → peritoneum → surface of the liver → perihepatitis (inflammation of the liver capsule). The characteristic finding is "violin-string adhesions" between the liver capsule and parietal peritoneum seen on laparoscopy. It is listed in Harrison's Chapter 161 as a local complication of untreated gonococcal infection in females (along with endometritis, salpingitis, tubo-ovarian abscess, bartholinitis, peritonitis). Treatment: treat the underlying gonorrhea + chlamydia.

Case 7 A 30-year-old woman develops tenosynovitis of the right wrist and left knee pain (migratory polyarthralgia), a few pustular skin lesions on her extremities, and fever. She reports unprotected sexual intercourse 2 weeks ago.

Q: What is the diagnosis, and what is the classic triad?

Answer: Disseminated Gonococcal Infection (DGI) - classic triad:

Tenosynovitis (inflammation of tendon sheaths - migratory polyarthralgia/tenosynovitis)
Dermatitis (hemorrhagic pustular or vesicular skin lesions, typically <10 lesions)
Polyarthralgia (migratory)

This is distinct from the septic arthritis form of DGI (purulent, usually monoarticular). The dermatitis-tenosynovitis syndrome is the more common DGI presentation. Rarely, DGI progresses to endocarditis or meningitis. Treatment: ceftriaxone IV for DGI (7+ days).

Case 8 A gonorrhea patient is treated with cefixime (oral 3rd generation cephalosporin) 400 mg as a single dose. Two weeks later, a test of cure is positive.

Q: Why did cefixime fail and what is the current recommendation?

Answer: Per Harrison's Chapter 161: Cefixime has been REMOVED from the list of first-line agents because:

Rising MICs of N. gonorrhoeae against cefixime
Limited capacity to reach levels sufficiently above MICs in blood, urethra, cervix, and especially the pharynx (pharyngeal gonorrhea is hardest to treat)
Pharmacokinetically inferior to ceftriaxone for genital/pharyngeal gonorrhea

Correct treatment: Ceftriaxone 500 mg IM (parenteral administration achieves levels that greatly exceed MICs in all anatomic sites). Oral cefixime can only be considered in settings where ceftriaxone is unavailable, with close follow-up.

Case 9 A 55-year-old man with no known cardiac history develops slowly progressive fatigue and a new grade III/VI systolic murmur over 3 months. Echocardiogram shows a large vegetation on the mitral valve. Blood cultures are initially negative after 5 days of incubation. He reports good oral hygiene but recently had extensive dental work 3 months ago.

Q: What organisms should you specifically suspect, and what is the significance of negative blood cultures?

Answer: HACEK group endocarditis - the classic cause of culture-negative endocarditis with large vegetations and dental/oropharyngeal source. HACEK organisms are:

Fastidious (slow-growing, need 5-21 days in culture media)
Part of normal oropharyngeal flora → dental procedures → bacteremia → endocarditis
Blood cultures may be negative at 5 days because standard culture bottles may not detect these slow-growing organisms (laboratories now use automated systems that extend incubation)

Organisms: Haemophilus, Aggregatibacter, Cardiobacterium, Eikenella, Kingella. Aggregatibacter spp. is the most common HACEK endocarditis cause. Treatment: ceftriaxone 2g/d.

Case 10 A microbiology plate from a patient with endocarditis grows a small gram-negative rod that is resistant to clindamycin. The isolate is susceptible to ceftriaxone and penicillin.

Q: Which specific HACEK organism is this, and what is its other characteristic feature?

Answer: Eikenella corrodens - the only HACEK organism with intrinsic resistance to clindamycin. Other characteristic features of E. corrodens:

"Corrodes" (pits) agar surface when colonies are removed
Part of normal oral flora
Classic bite wound infection (human bites) - important to remember: human bite wounds → treat with amoxicillin-clavulanate (covers both Eikenella and other oral flora)
Treatment for endocarditis: ceftriaxone 2g/d (per treatment table); avoid clindamycin

Case 11 A 4-year-old child develops septic arthritis of the left knee. Blood cultures grow a small fastidious gram-negative coccobacillus. There is no history of dental work.

Q: Which HACEK organism most commonly causes septic arthritis in young children?

Answer: Kingella kingae - the most common cause of septic arthritis and osteomyelitis in children (typically under 5 years old) among the HACEK organisms. K. kingae is part of the normal oral flora in children and is more likely to cause skeletal infections in this age group than endocarditis (unlike other HACEK members which primarily cause endocarditis). It often follows a URI or stomatitis. Treatment: beta-lactam antibiotics; susceptible to penicillin and cephalosporins.

Case 12 A previously healthy 12-year-old boy develops fever, severe unilateral facial pain, and nasal congestion after a URI. He progresses to right orbital swelling and proptosis. Sinus CT shows pan-sinusitis.

Q: What organism should be suspected if Gram stain of sinus fluid shows gram-negative diplococci that produce a "hockey puck sign" on culture?

Answer: Moraxella catarrhalis (from the same chapter as HACEK). Characteristic features:

Gram-negative diplococcus (resembles Neisseria on Gram stain - this is why it is often missed)
"Hockey puck sign": colonies can be slid across the agar surface without disruption (unlike Neisseria colonies which break apart)
After 48h: pink-colored, larger than Neisseria colonies
90% produce β-lactamase → resistant to amoxicillin alone
Causes otitis media in children (15-20% of cases) and sinusitis
Treatment: amoxicillin-clavulanate, extended-spectrum cephalosporins, macrolides, TMP-SMX, fluoroquinolones

Case 13 A patient with meningococcal meningitis is treated with penicillin G. The public health team is deciding whether the patient needs additional prophylaxis.

Q: Does treatment of meningococcal disease with penicillin eliminate nasopharyngeal carriage?

Answer: No. Per Harrison's Chapter 160: if the index patient is treated with an antibiotic that does NOT reliably clear nasopharyngeal colonization (penicillin is one such example), the patient themselves should receive a prophylactic agent at the END of treatment to prevent relapse and onward transmission. Ceftriaxone reliably clears carriage (97% effective). Penicillin treats invasive disease but may leave the nasopharyngeal reservoir intact. This is a high-yield point about the difference between treating infection and eradicating carriage.

Case 14 A 23-year-old heterosexual woman presents with a painless purulent vaginal discharge and mild pelvic discomfort. Testing confirms N. gonorrhoeae infection. She mentions her male partner takes recreational drugs and has multiple partners.

Q: Explain why the gonococcus has such a remarkable ability to evade the immune system, and does she have protective immunity after this infection?

Answer: Key immune evasion mechanisms of N. gonorrhoeae (Harrison's Chapter 161):

High polyploidy (3 genome copies per cell) → rapid antigenic variation via recombination
Phase variation of surface proteins (pili, Opa proteins) → the immune system cannot keep up
Rmp (Reduction Modifiable Protein/Protein III) antibodies: women infected with gonorrhea may develop Rmp antibodies that BLOCK bactericidal antibodies to porin and LOS → paradoxically makes them MORE susceptible to reinfection
Rmp has little interstrain variation → these blocking antibodies can block killing of ALL gonococci

Protective immunity is NOT reliably acquired from prior infection. This is a major reason why gonorrhea has no vaccine and reinfection is common. The Rmp blocking mechanism is a clever immune evasion strategy unique to gonococci.

TOPIC 5: FUNGAL INFECTIONS

13 Cases

Case 1 A 32-year-old HIV-positive man (CD4 count 65 cells/μL) develops worsening headache over 3 weeks, low-grade fever, and subtle personality changes. CSF analysis: WBC 5 cells/μL (mostly lymphocytes), protein mildly elevated, glucose normal. CSF India ink stain is positive.

Q: What is the diagnosis, and why does the CSF show minimal inflammation?

Answer: Cryptococcal meningoencephalitis (Cryptococcus neoformans). India ink stain shows encapsulated yeast with a clear halo (the polysaccharide capsule). Key teaching point: Cryptococcal meningitis is notorious for causing minimal CSF inflammation (low WBC count, near-normal glucose) despite serious infection. This is because:

The large polysaccharide capsule inhibits phagocytosis AND suppresses host immune response
In profoundly immunocompromised patients (CD4 <100), even less cellular response

Cryptococal antigen (CrAg) in serum and CSF is the most sensitive/specific test. Treatment: Amphotericin B liposomal + flucytosine x 2 weeks (induction) → fluconazole 400 mg/d x 8 weeks (consolidation) → fluconazole 200 mg/d maintenance.

Case 2 After being started on antiretroviral therapy (ART), a patient with cryptococcal meningitis develops worsening headache and increasing intracranial pressure (opening pressure 38 cm H₂O). His CSF culture is now sterile.

Q: What is happening and how do you manage the elevated ICP?

Answer: Immune Reconstitution Inflammatory Syndrome (IRIS) - as ART restores immune function, the recovering immune system mounts an inflammatory response against residual cryptococcal antigens → worsening symptoms despite sterile cultures. For elevated ICP in cryptococcal meningitis:

Serial therapeutic lumbar punctures to relieve pressure (remove enough CSF to bring opening pressure to ≤20 cm H₂O or reduce it by 50%)
⚠️ Corticosteroids are NOT routinely recommended for cryptococcal ICP management (unlike bacterial meningitis) - steroids may worsen fungal disease
For refractory ICP: lumbar drain or ventriculoperitoneal shunt

Case 3 A 55-year-old diabetic woman in diabetic ketoacidosis presents with headache, right-sided facial pain, and right-sided proptosis. Examination reveals a black necrotic eschar on the right hard palate. She is febrile and confused.

Q: What is the diagnosis, what is the imaging and biopsy finding, and what is the MOST critical treatment step besides antifungals?

Answer: Rhinocerebral mucormycosis - classic triad: DKA + black necrotic eschar/palate + proptosis (orbital extension). Pathology: biopsy shows broad, non-septate (pauciseptate), ribbon-like hyphae with right-angle branching. Compare to Aspergillus: narrow, septate, 45° angle branching.

Most critical step besides antifungals: SURGICAL DEBRIDEMENT (removal of all necrotic tissue) - antifungals alone are insufficient because mucormycosis causes vascular thrombosis → ischemic tissue where drugs cannot penetrate. Triple approach: Correct DKA + Liposomal Amphotericin B (highest doses) + Aggressive surgical debridement.

⚠️ Voriconazole has NO activity against Mucor - this is a high-yield exam trap.

Case 4 A 28-year-old man with acute leukemia and profound neutropenia (ANC 50 cells/μL) for 3 weeks develops fever unresponsive to broad-spectrum antibiotics. CT chest shows bilateral pulmonary nodules with a "halo sign" (ground-glass opacity surrounding each nodule). Serum galactomannan is positive (index 2.8).

Q: What is the diagnosis and why does the halo sign appear?

Answer: Invasive Pulmonary Aspergillosis (IPA) in a neutropenic host. The halo sign represents:

Central nodule = area of fungal infarction/necrosis (Aspergillus is angioinvasive - invades blood vessels → thrombosis → infarction)
Surrounding ground-glass halo = hemorrhagic ring around the infarct (blood oozing into surrounding alveoli from the damaged vessel)

The halo sign is an EARLY sign of IPA. As the patient's neutrophils recover (or with treatment), the necrotic center cavitates and forms the "air crescent sign" (air between the necrotic core and surrounding tissue) - this is a LATER sign indicating beginning recovery. Treatment: Voriconazole (first line for IPA). A. terreus is resistant to amphotericin B.

Case 5 A 24-year-old asthmatic woman with chronic sinusitis presents with recurrent wheezing episodes, central bronchiectasis on CT, peripheral eosinophilia of 1,200 cells/μL, total serum IgE of 2,400 IU/mL, and positive Aspergillus-specific IgE on RAST testing.

Q: What is the diagnosis and what type of hypersensitivity is involved?

Answer: Allergic Bronchopulmonary Aspergillosis (ABPA). Involves TWO types of hypersensitivity:

Type I (IgE-mediated): Aspergillus antigens bind IgE on mast cells → immediate bronchoconstriction → elevated total IgE + Aspergillus-specific IgE
Type III (immune complex-mediated): Aspergillus precipitins (IgG antibodies) form immune complexes → complement activation → tissue damage → central bronchiectasis

Diagnostic criteria: Asthma or CF + elevated total IgE >417 IU/mL + positive Aspergillus IgE + peripheral eosinophilia + central bronchiectasis + possibly pulmonary infiltrates. Treatment: oral corticosteroids (to suppress immune reaction) + itraconazole (antifungal to reduce fungal burden).

Case 6 A 60-year-old man with old tuberculosis (now cured) presents with recurrent hemoptysis. CXR shows a cavity in the right upper lobe with a mobile mass inside that shifts with position changes. CT confirms a round opacity within the cavity with a surrounding air crescent ("Monod sign").

Q: What is the diagnosis, and does this require antifungal treatment?

Answer: Pulmonary aspergilloma ("fungus ball"). The mass is a ball of Aspergillus hyphae, fibrin, mucus, and cellular debris colonizing a pre-existing cavity (from prior TB). The "Monod sign" (also called "air crescent sign" here - mass within cavity with air surrounding it) on CT is pathognomonic. The mass moves with gravity (shifts with position changes).

Management: In asymptomatic patients - observation only (antifungal drugs penetrate poorly into the cavity). In patients with hemoptysis (which can be massive and life-threatening): bronchial artery embolization → surgery for massive/refractory bleeding. Antifungal treatment has limited evidence for aspergilloma; itraconazole may reduce hemoptysis risk in some patients.

Case 7 A 22-year-old construction worker in Phoenix, Arizona develops a flu-like illness with fever, cough, chest pain, and an erythematous nodular rash on his shins (erythema nodosum) after excavating a building site.

Q: What is the diagnosis, and what does the erythema nodosum tell you about prognosis?

Answer: Primary pulmonary coccidioidomycosis ("Valley Fever" - Coccidioides immitis). Classic Arizona desert/California exposure + construction work (disturbs soil containing arthroconidia). The erythema nodosum (tender red nodules on shins = panniculitis from immune complex deposition) is an immune reaction to the fungus - it is actually a marker of a robust immune response and indicates a BETTER prognosis (the immune system is fighting effectively). Other immune reactions: erythema multiforme. Treatment for mild/self-limited disease: fluconazole or watchful waiting. Severe/disseminated: amphotericin B.

Case 8 A 38-year-old woman who lives near the Ohio River Valley develops fever, cough, mediastinal lymphadenopathy, and hepatosplenomegaly 3 weeks after cleaning out a bat-infested barn. CBC shows pancytopenia. Bone marrow biopsy shows intracellular yeast forms within macrophages.

Q: What is the diagnosis and what test is most sensitive for diagnosis?

Answer: Progressive Disseminated Histoplasmosis (Histoplasma capsulatum). Classic exposure: bird or bat droppings in Ohio/Mississippi River valleys. H. capsulatum is a dimorphic fungus (mold in environment, yeast at body temperature). Intracellular yeast within macrophages on bone marrow biopsy is pathognomonic. Key features: hepatosplenomegaly, pancytopenia (marrow infiltration), fever.

Most sensitive test: Urine Histoplasma antigen (sensitivity >90% for disseminated disease; also serum antigen). Serology less useful in immunocompromised. Treatment: liposomal amphotericin B for severe disseminated disease → itraconazole step-down and suppressive therapy.

Case 9 A 45-year-old post-renal transplant patient on tacrolimus, mycophenolate, and prednisone develops fever, a white oral pseudomembrane that scrapes off, and severe odynophagia. Endoscopy reveals linear white plaques throughout the esophagus.

Q: What is the diagnosis, what predisposed him, and what is the treatment hierarchy?

Answer: Oropharyngeal candidiasis (thrush) + Esophageal candidiasis (Candida sp.) - esophageal candidiasis is AIDS/immunocompromise-defining. Predisposing factors: immunosuppressive drugs (prednisone, tacrolimus, mycophenolate) for transplant rejection prevention.

Treatment hierarchy:

Oropharyngeal only (thrush): Topical nystatin swish/swallow OR oral fluconazole 150-200 mg/d x 7-14 days
Esophageal candidiasis: Must treat systemically - oral fluconazole 200-400 mg/d x 14-21 days (first-line)
Invasive/candidemia: Echinocandin (caspofungin, micafungin, anidulafungin) = first line; fluconazole for stable, susceptible C. albicans

Case 10 A 58-year-old patient in the ICU on broad-spectrum antibiotics, TPN, and a central venous catheter develops new fever of 38.9°C. Blood cultures grow yeast (budding yeast with pseudohyphae on Gram stain). Ophthalmology is urgently consulted.

Q: Why was ophthalmology consulted, and what is the most serious complication of candidemia that drives antifungal choice?

Answer: Candidemia can disseminate to the eyes causing Candida endophthalmitis (chorioretinitis → vitritis) which can lead to permanent vision loss. Ophthalmology is consulted to assess for ocular seeding via dilated fundoscopic exam (look for white fluffy chorioretinal lesions). Other hematogenous seeding targets: heart (endocarditis - common with C. parapsilosis in IV drug users or long-term central lines), bones, joints, CNS, kidneys.

Treatment: Echinocandin (caspofungin/micafungin) = first-line for most candidemia. Remove the central venous catheter (biofilm reservoir - critical step). Duration: 14 days after last positive blood culture AND resolution of symptoms. Fluconazole can be de-escalated to once blood cultures clear and patient is stable with a susceptible isolate.

Case 11 A 35-year-old woman with recurrent vulvovaginal candidiasis (4 episodes/year) asks what organism is causing her infections. She is otherwise healthy. Her last two episodes did NOT respond to a single dose of fluconazole.

Q: What non-albicans Candida species should you suspect, and why is fluconazole failing?

Answer: Most likely Candida glabrata (now reclassified as Nakaseomyces glabrata) OR Candida krusei. Key resistance points:

C. glabrata: has intrinsic/dose-dependent susceptibility to fluconazole - standard single-dose fluconazole is often insufficient; may need higher doses or echinocandin
C. krusei: intrinsically resistant to fluconazole - must use echinocandin or voriconazole
C. albicans is usually fluconazole-susceptible

For recurrent vulvovaginal candidiasis: treat acute episode + consider weekly fluconazole 150 mg PO x 6 months suppressive therapy. Culture and speciation are important to guide therapy when azoles fail.

Case 12 A 70-year-old man with COPD and a previous TBresection cavity develops a slowly progressive illness over 6 months: weight loss, chronic cough, new cavitation within the old TB cavity, and hemoptysis. Serum IgG antibodies to Aspergillus are positive. Galactomannan is negative. He is NOT neutropenic.

Q: What category of aspergillosis does this represent?

Answer: Chronic Pulmonary Aspergillosis (CPA) - specifically Chronic Cavitary Pulmonary Aspergillosis (CCPA). This is distinct from:

Aspergilloma: Static ball within cavity, asymptomatic
IPA: Neutropenic/severely immunocompromised, acute, angioinvasive
ABPA: Asthma/CF, immune-mediated, eosinophilia

CPA affects patients with structural lung disease (old TB, COPD, sarcoidosis, bullae) and mild immune dysfunction. Features: progressive cavitation over months-years, positive Aspergillus IgG (not just skin test), negative/low galactomannan (not the same as IPA). Treatment: long-term oral itraconazole or voriconazole (often 1-2+ years); hemoptysis managed with bronchial artery embolization.

Case 13 During morning rounds, a nurse tells you that a patient started on voriconazole for Aspergillus lung infection has been prescribed rifampin by the TB team for possible TB co-infection.

Q: Why is this drug combination potentially dangerous?

Answer: Critical drug interaction: Rifampin is a potent CYP450 inducer (particularly CYP3A4, CYP2C19) - the same enzymes that metabolize azole antifungals (voriconazole, itraconazole, fluconazole to varying degrees). Rifampin + voriconazole → dramatically reduced voriconazole plasma levels (by >90%) → subtherapeutic antifungal levels → treatment failure of invasive aspergillosis.

This is one of the absolute contraindications to voriconazole - the combination is listed as contraindicated. Options: use alternative antifungals (liposomal amphotericin B doesn't have this interaction, or isavuconazole with close monitoring) OR reconsider rifampin-based TB therapy. Always check drug interactions when prescribing azole antifungals.

🎯 FINAL EXAM QUICK-RECALL: TOP HIGH-YIELD CLINICAL PEARLS

Clinical Scenario	Diagnosis	Key Teaching Point
Patient from malarious area + fever	Malaria	ALWAYS consider; don't forget locally acquired cases in FL, TX
Palpebral edema + myalgias + eosinophilia	Trichinellosis	From undercooked pork
Most common parasitic eosinophilic meningitis	Angiostrongylus cantonensis	Raw snails/slugs
"Putrid" foul-smelling lung abscess	Anaerobic (primary) lung abscess	Right posterior upper lobe; metronidazole ALONE not effective
Lung abscess + septic emboli in IV drug user	Tricuspid endocarditis (S. aureus)	Multiple bilateral lesions
Lemierre's syndrome	Fusobacterium necrophorum	Pharynx → neck → jugular vein → septic emboli
CF + male infertility	Bilateral absent vas deferens (CBAVD)	Spermatogenesis INTACT; 99% infertile
Sweat Cl⁻ >60 mEq/L	Cystic fibrosis	CFTR = Cl⁻/HCO₃⁻ channel
Non-blanching purpuric rash + fever + college dormitory	Meningococcemia	Emergency: IV ceftriaxone immediately
"Hockey puck sign" on culture	Moraxella catarrhalis	>90% beta-lactamase positive; amoxicillin fails
Eikenella + clindamycin	Resistant	HACEK; use ceftriaxone instead
DKA + black palate necrosis	Rhinocerebral mucormycosis	Surgery + Ampho B; voriconazole = INEFFECTIVE
Halo sign on CT + neutropenia	Invasive Aspergillosis	Voriconazole first line; A. terreus resistant to Ampho B
Pigeon droppings + meningitis + minimal CSF inflammation	Cryptococcus	India ink; CrAg test; Ampho B + 5-FC induction
Arizona desert exposure + erythema nodosum	Coccidioidomycosis	E. nodosum = GOOD prognosis (strong immune response)
Ohio River Valley + bat droppings + pancytopenia	Disseminated Histoplasmosis	Urine antigen most sensitive
Rifampin + voriconazole	Dangerous interaction	Rifampin induces CYP → subtherapeutic voriconazole levels

Good luck on your exam! Let me know if you want me to create fill-in-the-blank questions, matching exercises, or a timed mock exam for any of these topics.

MCQs

Here are 10-15 MCQs per topic - all in proper board exam format (single best answer), with full explanations.

📝 MCQ BANK — 3RD YEAR INTERNAL MEDICINE EXAM

Based on Your Harrison's 22nd Ed + DMSF Lecture Files

TOPIC 1: PARASITIC INFECTIONS

15 MCQs

Q1. A 30-year-old traveler returns from sub-Saharan Africa with fever, chills, and headache. Blood smear shows multiple ring forms within a single RBC and banana-shaped gametocytes. Which of the following is the MOST feared complication of this infection?

A. Splenic rupture
B. Megaloblastic anemia
C. Cerebral malaria
D. Eosinophilic meningitis
E. Biliary obstruction

✅ Answer: C - Cerebral malaria The banana-shaped gametocytes + multiple rings per RBC = P. falciparum. Its unique ability to cause infected RBC sequestration in cerebral microvasculature (via PfEMP1 protein) leads to cerebral malaria (coma, seizures, death). Splenic rupture is more typical of P. vivax. Megaloblastic anemia = D. latum (fish tapeworm). Eosinophilic meningitis = Angiostrongylus.

Q2. A patient with P. vivax malaria is treated with chloroquine and recovers. Three months later, he has a relapse of fever while vacationing in a non-endemic area. What is the mechanism of this relapse?

A. Re-infection from a new mosquito bite
B. Drug-resistant erythrocytic forms
C. Reactivation of persistent liver hypnozoites
D. Auto-infection cycle in the intestine
E. Antigenic variation of merozoites

✅ Answer: C - Reactivation of persistent liver hypnozoites P. vivax and P. ovale produce hypnozoites - dormant liver-stage forms that persist after the blood-stage is cleared. Chloroquine only treats the blood stage. Primaquine (or tafenoquine) must be added to eradicate the liver reservoir and prevent relapse. Chloroquine alone = incomplete treatment for P. vivax/P. ovale.

Q3. A patient with HIV (CD4 = 180 cells/μL) is started on ibrutinib for CLL. Which of the following prophylactic regimens should be initiated?

A. Fluconazole 200 mg/d
B. TMP-SMX one double-strength tablet daily
C. Isoniazid 300 mg/d
D. Dapsone 100 mg/d
E. Azithromycin 1.2 g/week

✅ Answer: B - TMP-SMX one DS tablet daily PCP prophylaxis is indicated here - ibrutinib (a BTK inhibitor) is explicitly listed in Harrison's as an immunosuppressant warranting PCP prophylaxis. TMP-SMX is the most effective prophylactic drug with very few PCP breakthroughs when reliably taken. Fluconazole = antifungal prophylaxis (not indicated here). Isoniazid = TB prophylaxis. Azithromycin = MAC prophylaxis (CD4 <50). Dapsone cross-reacts with sulfonamides and is second-line.

Q4. A 40-year-old man from West Africa presents with progressive daytime somnolence, behavioral changes, and a trypanosomal chancre at a bite site 3 months ago. CSF analysis shows pleocytosis with trypanosomes. Which feature BEST distinguishes his infection from the East African form?

A. Presence of a painful chancre at the bite site
B. Late CNS involvement (months to years after initial infection)
C. Transmission by tsetse fly
D. Early CNS involvement (weeks after initial infection)
E. Cyclical fever pattern

✅ Answer: B - Late CNS involvement (months to years) This is T. brucei gambiense (West African sleeping sickness) - characterized by late CNS involvement over months to years. T. brucei rhodesiense (East African) causes early rapid CNS involvement within weeks. Both have a trypanosomal chancre and are transmitted by tsetse fly. Cyclical fever is more typical of malaria. The late progression is why T.b. gambiense is "sleeping sickness" - the CNS stage disrupts the sleep-wake cycle late in disease.

Q5. A 22-year-old woman develops bloody diarrhea after returning from Bangladesh. Stool microscopy shows trophozoites with ingested RBCs. Which of the following is MOST correct regarding diagnosis?

A. Trophozoites with ingested RBCs confirm E. histolytica infection
B. Morphology alone can distinguish E. histolytica from E. dispar
C. E. dispar is more pathogenic than E. histolytica
D. Both E. histolytica and E. dispar have identical morphology but differ clinically/immunologically
E. Culture is the gold standard for distinguishing the two species

✅ Answer: D - Identical morphology, differ clinically/immunologically This is the critical diagnostic challenge from Harrison's Chapter 228. E. histolytica (invasive, pathogenic) and E. dispar (non-invasive, more common globally) are morphologically identical - you CANNOT distinguish them by microscopy alone. Diagnosis requires PCR, ELISA antigen detection, or isoenzyme analysis. The finding of trophozoites with ingested RBCs suggests E. histolytica (since E. dispar rarely ingests RBCs) but is not definitive. E. dispar is NOT pathogenic.

Q6. A patient is successfully treated for invasive amebic liver abscess with metronidazole. The attending physician adds a second agent before discharge. Which of the following is the MOST appropriate addition and its reason?

A. Chloroquine - for prophylaxis against recurrent blood-stage infection
B. Diloxanide furoate - to eliminate intestinal luminal cysts
C. Pyrimethamine - to prevent Toxoplasma reactivation
D. Albendazole - to treat co-existing intestinal helminths
E. Tinidazole - as a second tissue amebicide

✅ Answer: B - Diloxanide furoate to eliminate intestinal luminal cysts Metronidazole is a tissue amebicide - it treats invasive disease but does NOT eliminate intestinal luminal cysts. Without a luminal amebicide (diloxanide furoate, paromomycin, or iodoquinol), the intestinal reservoir persists → risk of relapse and ongoing transmission. This two-step approach (tissue amebicide → luminal amebicide) is standard management for all forms of invasive amebiasis.

Q7. Which of the following statements about albendazole is CORRECT according to Harrison's Chapter 229?

A. It is well absorbed from the GI tract, making it ideal for tissue infections
B. It binds β-tubulin, inhibiting microtubule polymerization and glucose uptake
C. Dexamethasone decreases plasma levels of albendazole sulfoxide by 50%
D. It is the drug of choice for Chagas disease
E. It causes frequent severe cardiotoxicity

✅ Answer: B - Binds β-tubulin, inhibiting microtubule polymerization and glucose uptake Albendazole's mechanism: selectively binds free β-tubulin in nematodes → inhibits tubulin polymerization → disrupts microtubule-dependent glucose uptake → starvation → death. It is poorly absorbed from the GI tract (good for intestinal helminths, disadvantage for tissue infections). Dexamethasone and praziquantel increase (not decrease) albendazole sulfoxide levels by ~50%. Benznidazole/nifurtimox = Chagas. Cardiotoxicity = emetine/dehydroemetine.

Q8. A 55-year-old asplenic woman develops fever and hemolytic anemia after spending summer in Cape Cod, Massachusetts. Blood smear shows "Maltese cross" (tetrad) forms. Which of the following is MOST accurate?

A. This infection is transmitted by Anopheles mosquitoes
B. The organism multiplies in liver hepatocytes
C. Splenectomy reduces severity of infection
D. The organism is geographically limited and splenectomy worsens infection
E. Treatment requires primaquine to eradicate liver forms

✅ Answer: D - Geographically limited and splenectomy worsens infection The "Maltese cross/tetrad" = Babesia microti (babesiosis). It is transmitted by Ixodes ticks (not Anopheles mosquitoes) and is geographically limited to the northeastern and midwestern USA. The spleen is critical for clearing parasitized RBCs - asplenic patients have significantly worse infection (splenectomy worsens, not reduces severity). Babesia does NOT have liver forms (unlike Plasmodium) - no primaquine needed. Treatment: atovaquone + azithromycin (mild) or clindamycin + quinine (severe).

Q9. A 14-year-old boy from rural Philippines develops progressive dyspnea and facial puffiness 10 days after eating raw seafood. CBC shows WBC 15,000 with 45% eosinophils. CSF analysis reveals eosinophilic pleocytosis. Which organism is responsible?

A. Gnathostoma spinigerum
B. Angiostrongylus cantonensis
C. Trichinella spiralis
D. Schistosoma mansoni
E. Strongyloides stercoralis

✅ Answer: B - Angiostrongylus cantonensis This is the most common parasitic cause of eosinophilic meningitis (Harrison's Chapter 228). Acquired by eating raw snails/slugs or contaminated vegetables in Southeast Asia/Pacific. Larvae penetrate the intestine → migrate to brain → die → massive eosinophilic response → eosinophilic meningitis. Gnathostoma can also cause eosinophilic meningitis but is less common and often more severe (paralysis, brain hemorrhage). Trichinella = myalgias + palpebral edema (NOT meningitis primarily). Schistosoma = liver/bladder. Strongyloides = hyperinfection in immunocompromised.

Q10. Which of the following tapeworm infections occurs when humans serve as the INTERMEDIATE host (not definitive host)?

A. Intestinal Taenia saginata infection from undercooked beef
B. Intestinal Diphyllobothrium latum infection from raw fish
C. Taenia solium cysticercosis from ingesting OVA
D. Intestinal Hymenolepis nana from grain beetles
E. Intestinal Taenia solium from undercooked pork

✅ Answer: C - Taenia solium cysticercosis from ingesting OVA The key concept from Harrison's: when humans ingest larvae → act as definitive host → intestinal infection (mild). When humans ingest OVA → act as intermediate host → larvae hatch, penetrate intestine, migrate to tissues (brain, muscle, eye) → SEVERE somatic infection (neurocysticercosis). Options A, B, D, E all involve ingesting larvae/organisms and resulting in intestinal infection. Option C (ingesting T. solium OVA, not larvae) results in cysticercosis - humans becoming the intermediate host with larval tissue invasion.

Q11. A patient on TMP-SMX for PCP prophylaxis develops severe erythema multiforme (Stevens-Johnson Syndrome). Which alternative prophylactic agent is CONTRAINDICATED due to cross-reactivity with sulfonamides?

A. Atovaquone
B. Aerosol pentamidine
C. Dapsone
D. Pyrimethamine alone
E. Clindamycin

✅ Answer: C - Dapsone Harrison's Chapter 228 explicitly states: "Dapsone cross-reacts with sulfonamides in a substantial fraction of patients and is rarely useful in patients with a history of life-threatening reactions to TMP-SMX." Best alternatives for severe sulfonamide allergy: Atovaquone (effective and well-tolerated) or monthly aerosol pentamidine (less effective; doesn't protect poorly-ventilated areas). Pentamidine aerosol is a non-sulfonamide option. The life-threatening nature of this reaction (SJS) means dapsone is absolutely contraindicated here.

Q12. A Brazilian patient develops dilated cardiomyopathy and megaesophagus years after an acute febrile illness in childhood. Serology shows positive anti-T. cruzi antibodies. Which of the following BEST describes the mechanism of transmission?

A. Bite of an Anopheles mosquito during daytime
B. Ingestion of undercooked wild game meat
C. Scratching feces of infected reduviid bug into bite wound
D. Skin penetration by cercariae in freshwater
E. Bite of a tsetse fly in the jungle

✅ Answer: C - Scratching feces of infected reduviid bug into bite wound Chagas disease (T. cruzi) is transmitted by reduviid (triatomine/kissing) bugs in South/Central America. The bug feeds at night → defecates near the bite site → the person scratches → feces (containing trypanosomes) are rubbed into the wound. It can also be transmitted via blood transfusion, organ transplant, and mother-to-child. NOT mosquito (malaria) or tsetse fly (African trypanosomiasis) or cercariae (schistosomiasis).

Q13. Leishmania donovani causes visceral leishmaniasis (kala-azar). Which of the following is the MOST accurate statement about this infection?

A. It is transmitted by Ixodes ticks in sub-Saharan Africa
B. It causes hepatosplenomegaly, fever, and wasting and is an AIDS-defining illness
C. Humans infected with L. donovani reliably develop protective immunity
D. It primarily infects skeletal muscle cells
E. Treatment requires praziquantel

✅ Answer: B - Hepatosplenomegaly, fever, wasting; AIDS-defining illness From the parasites-by-organ-system table in Harrison's Chapter 228. L. donovani = visceral leishmaniasis → tropics/subtropics → hepatosplenomegaly + fever + wasting + pancytopenia (marrow infiltration). AIDS-defining infection (disseminates in HIV/AIDS with CD4 <200). Transmitted by sandfly (not Ixodes ticks). Infects macrophages (not skeletal muscle). Praziquantel = schistosomiasis/tapeworms. Treatment of VL: liposomal amphotericin B or miltefosine.

Q14. A 45-year-old Egyptian farmer presents with portal hypertension, esophageal varices, and splenomegaly. He has no history of alcohol use and hepatitis serology is negative. He reports wading in irrigation canals throughout his life.

Q: Which schistosome species is responsible, and what is the primary pathologic mechanism?

A. S. haematobium - bladder wall inflammation → cirrhosis
B. S. mansoni - mesenteric vessel egg deposition → granuloma formation → portal hypertension
C. S. japonicum - urinary tract invasion → hepatic fibrosis
D. S. haematobium - mesenteric vessel invasion → portal hypertension
E. S. mansoni - direct hepatocyte invasion → cirrhosis

✅ Answer: B - S. mansoni - mesenteric vessel egg deposition → granuloma formation → portal hypertension S. mansoni and S. japonicum migrate to mesenteric/portal vessels. Eggs deposited in portal vein → liver → granuloma formation around eggs → fibrosis → portal hypertension → esophageal varices. This is "pipestem fibrosis" or Symmers' fibrosis. S. haematobium targets urinary tract (bladder, ureters) → hematuria, bladder cancer. Egypt has high S. mansoni endemicity from Nile irrigation canals. Note: cirrhosis = fibrosis without nodular regeneration (unlike alcoholic cirrhosis - schistosomal portal hypertension is "pre-sinusoidal").

Q15. Which of the following antiparasitic drug-indication pairs is INCORRECT?

A. Albendazole - Neurocysticercosis
B. Triclabendazole - Fascioliasis
C. Benznidazole - Chagas disease
D. Diloxanide furoate - Invasive amebic liver abscess (tissue stage)
E. Mebendazole - Trichuriasis

✅ Answer: D - Diloxanide furoate for invasive amebic liver abscess Diloxanide furoate is a luminal amebicide - it works in the intestinal lumen and eliminates cysts. It does NOT treat invasive/tissue disease. The tissue amebicide for invasive amebiasis (liver abscess) is metronidazole (or tinidazole). Diloxanide furoate is used AFTER metronidazole to eliminate the luminal reservoir. All other pairings are correct: albendazole = cysticercosis, triclabendazole = fascioliasis, benznidazole = Chagas, mebendazole = trichuriasis.

TOPIC 2: RESPIRATORY PHYSIOLOGY & APPROACH TO RESPIRATORY DISEASE

12 MCQs

Q1. A 50-year-old COPD patient describes his breathlessness as "I can't get a deep breath - my chest feels locked." A 60-year-old heart failure patient describes "I feel like I'm drowning - air hunger." According to Harrison's, what do these descriptions indicate?

A. Both describe the same pathophysiology
B. "Chest tightness/unable to get a deep breath" = CHF; "air hunger" = COPD
C. "Chest tightness/unable to get a deep breath" = obstructive; "air hunger" = CHF
D. Both indicate obstructive lung disease
E. Dyspnea quality is unreliable for identifying etiology

✅ Answer: C From Harrison's Chapter 295: The quality/character of dyspnea provides diagnostic clues:

"Chest tightness / inability to get a deep breath" → Obstructive lung disease (asthma, COPD)

"Air hunger / sense of suffocation" → Congestive heart failure

This history-taking tool helps narrow the diagnosis before any testing. It reflects the different sensory mechanisms: airway receptors in obstruction vs. pulmonary vascular/J-receptors in CHF.

Q2. A patient performs spirometry. Despite maximal expiratory effort, flow does not increase beyond a certain point. What is the BEST explanation for this phenomenon?

A. Patient fatigue preventing adequate effort
B. The Bernoulli effect causing dynamic airway narrowing during forced expiration, creating effort-independent flow limitation
C. Fixed upper airway obstruction limiting flow equally in both directions
D. Loss of lung elastic recoil preventing adequate airway expansion
E. Increased airway resistance due to bronchospasm

✅ Answer: B - Bernoulli effect causing dynamic airway narrowing during forced expiration From Harrison's Chapter 296: During forced expiration, gas accelerates toward the mouth → intraluminal pressure drops (Bernoulli effect, same principle as airplane wing lift) → transmural pressure decreases → airways narrow. If effort increases → velocity increases → airways narrow MORE → no net increase in flow. This is dynamic flow limitation - maximal expiratory flow is effort-independent at any given lung volume. This is the physiologic basis of spirometry.

Q3. A 68-year-old man with emphysema has reduced maximal expiratory flow on spirometry. A 55-year-old woman with idiopathic pulmonary fibrosis (IPF) has elevated maximal expiratory flow relative to her lung volume. What accounts for this difference?

A. Emphysema increases airway resistance; IPF decreases it
B. Emphysema decreases lung elastic recoil; IPF increases it
C. Emphysema increases lung recoil; IPF decreases it
D. Both have increased (A-a)DO₂ for the same reason
E. IPF causes obstructive physiology; emphysema causes restrictive physiology

✅ Answer: B - Emphysema decreases recoil; IPF increases recoil From Harrison's Chapter 296: Maximal expiratory flow depends on lung elastic recoil pressure.

Emphysema: destruction of alveolar walls → reduced lung recoil → reduced maximal expiratory flow → obstructive pattern (scooped-out flow-volume loop)

IPF/Fibrosis: stiff, scarred lungs → increased lung recoil at any given volume → elevated maximal expiratory flow relative to lung volume → restrictive pattern (tall, narrow flow-volume loop)

IPF causes restrictive physiology (reduced TLC, preserved FEV₁/FVC), NOT obstructive.

Q4. A 45-year-old woman with a tracheal adenoma develops inspiratory stridor and flow-volume loop shows a plateau on the inspiratory limb with normal expiratory limb. What is the mechanism?

A. Dynamic intrathoracic airway collapse during expiration
B. Extrathoracic fixed obstruction limiting flow equally in both directions
C. Extrathoracic airway narrowing causing inspiratory airflow limitation via reduced transmural pressure
D. Increased lung elastic recoil reducing inspiratory flow
E. V/Q mismatch reducing inspiratory effort

✅ Answer: C - Extrathoracic narrowing causing inspiratory flow limitation From Harrison's Chapter 296: During inspiration, negative pleural pressures increase transmural pressure → airways normally expand. Inspiratory flow limitation rarely occurs from diffuse pulmonary disease. However, extrathoracic airway narrowing (tracheal adenoma, posttracheostomy stricture) creates a fixed narrowing at the extrathoracic level. During inspiration, the extrathoracic trachea is subject to atmospheric pressure outside and negative pressure inside → the fixed stenosis limits flow. This produces an inspiratory plateau on the flow-volume loop. Expiratory limb is normal because forced expiration increases intratracheal pressure past the obstruction.

Q5. A chest X-ray of a patient with newly diagnosed asthma is reported as "normal." The resident tells the patient "Good news - your lungs are fine." What is the MOST important teaching point here?

A. A normal CXR rules out significant asthma
B. CXR is the most sensitive test for airway disease
C. Many diseases of the airways and pulmonary vasculature are associated with a normal CXR
D. CT scan is not needed if CXR is normal
E. Normal CXR in asthma means the patient does not need spirometry

✅ Answer: C - Many airway/vascular diseases are associated with a normal CXR From Harrison's Chapter 295: "Many diseases of the respiratory system, particularly those of the airways and pulmonary vasculature, are associated with a normal chest radiograph." Asthma, early COPD, pulmonary hypertension, and pulmonary embolism can all have a completely normal CXR. The CXR showing "no acute cardiopulmonary disease" does NOT rule out respiratory pathology. The resident's statement is incorrect and potentially misleading. Spirometry (PFTs) is the appropriate next test to confirm obstructive physiology in asthma.

Q6. Spirometry result: FEV₁ = 1.8L (55% predicted), FVC = 3.9L (90% predicted), FEV₁/FVC = 0.46. Post-bronchodilator: FEV₁ = 2.3L (28% improvement, 500 mL increase). What is the diagnosis?

A. Restrictive lung disease - mild
B. Obstructive lung disease - fixed (no reversibility)
C. Obstructive lung disease with significant bronchodilator reversibility, consistent with asthma
D. Mixed obstructive-restrictive pattern
E. Normal spirometry - within acceptable range

✅ Answer: C - Obstructive with significant reversibility (asthma) Pattern analysis:

FEV₁/FVC = 0.46 (<0.70) → Obstructive pattern

FVC = 90% predicted → No restriction

Post-bronchodilator: FEV₁ improves 28% AND 500 mL → Significant reversibility (threshold: ≥12% AND ≥200 mL = significant; here both criteria are met with room to spare)

Significant reversibility = asthma (COPD typically shows ≤12% reversibility)

Restrictive = reduced TLC + preserved FEV₁/FVC. Mixed = both obstructive FEV₁/FVC + reduced TLC.

Q7. An ABG shows: PaO₂ = 65 mmHg, PaCO₂ = 40 mmHg, pH 7.40. Calculated (A-a)DO₂ = 32 mmHg (normal for age = 10 mmHg). What mechanism of hypoxemia does this indicate?

A. Pure hypoventilation
B. V/Q mismatch or intrapulmonary shunt
C. High altitude (reduced FiO₂)
D. Diffusion impairment only
E. Central hypoventilation with normal lung

✅ Answer: B - V/Q mismatch or intrapulmonary shunt From Harrison's Chapter 295-296:

Elevated (A-a)DO₂ = lung is responsible for the hypoxemia = V/Q mismatch or shunt

Pure hypoventilation → elevated PaCO₂ → normal (A-a)DO₂ (alveoli have less O₂ because CO₂ fills them, but the gradient between alveolar and arterial O₂ is normal)

High altitude → reduced PAO₂ → normal (A-a)DO₂

Here PaCO₂ is normal (40 mmHg) → the patient is NOT hypoventilating, yet has hypoxemia → the increased (A-a)DO₂ confirms a lung-based mechanism (V/Q mismatch or shunt)

Q8. Which imaging modality is MOST appropriate as the FIRST step in a patient presenting with acute dyspnea in the emergency room, where pneumothorax, pleural effusion, and consolidation are in the differential?

A. CT chest with contrast
B. PET-CT
C. Chest ultrasound
D. High-resolution CT (HRCT)
E. V/Q scan

✅ Answer: C - Chest ultrasound From Harrison's Chapter 295: "Clinicians should generally begin with ultrasound of the chest or a plain chest radiograph." Ultrasound is "often readily available and can rapidly diagnose pneumothorax, pleural effusion, and consolidation of lung parenchyma." It is bedside, fast, no radiation, and point-of-care. CT is more detailed but takes more time/resources. HRCT = best for parenchymal disease (ILD) not acute emergency triage. V/Q = PE evaluation. PET-CT = metabolic activity of lesions (malignancy).

Q9. A patient with COPD has FEV₁ 40% predicted and is hypercarbic (PaCO₂ 58 mmHg) with compensated respiratory acidosis (pH 7.37, HCO₃ 32). This pattern of hypercarbia in COPD results from which of the following?

A. Decreased lung recoil increasing FRC and trapping CO₂
B. V/Q mismatch causing CO₂ retention despite increased minute ventilation
C. Severe airway obstruction reducing ventilation → CO₂ accumulation (type II respiratory failure)
D. Increased diffusion distance for CO₂ across the alveolar membrane
E. Decreased respiratory rate from central depression

✅ Answer: C - Severe airway obstruction reducing ventilation → CO₂ accumulation From Harrison's Chapter 295-296: "Hypercarbia can accompany disorders of ventilation, as seen in severe airway obstruction (e.g., COPD) or progressive restrictive physiology." When FEV₁ falls severely (<40%), effective alveolar ventilation is so impaired that CO₂ cannot be exhaled adequately → CO₂ builds up → Type II Respiratory Failure (hypoxemic + hypercapnic). The compensated alkalosis (HCO₃ 32) indicates this is chronic. Note: COPD patients on home O₂ - don't give high-flow O₂ without caution (removes hypoxic drive in CO₂ retainers).

Q10. A 35-year-old woman with no prior lung disease develops sudden onset pleuritic chest pain, dyspnea, and tachycardia after a 14-hour flight. CXR is NORMAL. ABG: PaO₂ 68, (A-a)DO₂ elevated. What is the MOST appropriate next imaging step?

A. HRCT chest (no contrast)
B. PET-CT
C. Plain CXR repeat in 6 hours
D. CT pulmonary angiography (CTPA)
E. Chest ultrasound for effusion

✅ Answer: D - CT pulmonary angiography (CTPA) Clinical scenario: post-flight (prolonged immobility) + pleuritic chest pain + tachycardia + normal CXR + elevated (A-a)DO₂ = pulmonary embolism until proven otherwise. From Harrison's Chapter 295: CT with IV contrast "allows pulmonary vasculature to be assessed with particular utility for determination of pulmonary emboli." The normal CXR is actually typical of PE (airways/vasculature diseases often show normal CXR per Harrison's). CTPA is the gold standard imaging for PE. V/Q scan is an alternative if contrast is contraindicated.

Q11. During inspiration, which of the following changes in airway dynamics occurs according to the Bernoulli principle?

A. Intraluminal gas pressure falls, narrowing airways
B. More negative pleural pressures increase transmural pressure, promoting airway expansion
C. Acceleration of airflow causes airway collapse
D. Airway resistance increases maximally during inspiration
E. Dynamic flow limitation is most pronounced during inspiration

✅ Answer: B - More negative pleural pressures increase transmural pressure, promoting airway expansion From Harrison's Chapter 296: "The Bernoulli effect also applies during inspiration, but the more negative pleural pressures during inspiration lower the pressure outside of the airways, thereby increasing transmural pressure and promoting airway expansion." This is why inspiratory flow limitation seldom occurs with diffuse pulmonary disease - inspiration actively opens airways. The Bernoulli-related dynamic collapse (flow limitation) is an expiratory phenomenon. This also explains why asthma and COPD wheeze is worse on expiration, and why pursed-lip breathing (creates back-pressure = positive end-expiratory pressure) helps COPD patients.

Q12. A 55-year-old carpenter with a history of asbestos exposure for 20 years presents with progressive dyspnea. PFTs show TLC 62% predicted, FVC 65% predicted, FEV₁/FVC 0.80. The MOST likely pathology and PFT pattern is:

A. Obstructive - asbestos-induced bronchospasm
B. Restrictive - pleural/parenchymal fibrosis from asbestos
C. Normal - asbestos only causes pleural plaques without functional impairment
D. Mixed obstructive-restrictive - asbestos causes both emphysema and fibrosis
E. Obstructive - asbestos causes COPD-like disease

✅ Answer: B - Restrictive - pleural/parenchymal fibrosis From Harrison's Chapter 295: asbestosis causes restrictive physiology due to parenchymal fibrosis (and pleural disease). Pattern:

Reduced TLC (62%) → confirms restriction

Reduced FVC (65%)

FEV₁/FVC 0.80 (preserved, >0.70) → NO obstruction

Restrictive diseases include: parenchymal lung diseases (IPF, asbestosis), chest wall/pleura abnormalities, and neuromuscular disease. DLCO would also be reduced (impaired diffusion). Asbestos → pleural plaques (radiographic marker of exposure) + parenchymal fibrosis = asbestosis.

TOPIC 3: BRONCHIECTASIS, LUNG ABSCESS, CYSTIC FIBROSIS

15 MCQs

Q1. A 48-year-old woman with daily productive cough for 5 years presents for evaluation. CXR shows increased markings bilaterally. Which imaging finding on CT is MOST specific for confirming bronchiectasis?

A. Honeycombing with subpleural distribution
B. Ground-glass opacities with centrilobular nodules
C. Enlarged airway (ring) adjacent to normal-sized pulmonary artery ("signet ring sign")
D. Bilateral lower lobe consolidation with air bronchograms
E. Mediastinal lymphadenopathy with hilar calcifications

✅ Answer: C - Signet ring sign The signet ring sign on CT chest is the hallmark of bronchiectasis: an enlarged airway (the ring) sitting adjacent to a normal-sized pulmonary artery (the signet stone). Normally the airway and its adjacent artery are roughly equal in size - when the airway is dilated (bronchiectasis), this ratio is disturbed. On CXR, the less-specific "tram-track" sign shows dilated airway walls. CT is the imaging modality of choice for confirming bronchiectasis (per Dr. Platero's slides). Honeycombing = IPF. Ground-glass = acute inflammation/edema. Hilar calcifications = healed granulomatous disease.

Q2. According to the "vicious cycle hypothesis" of bronchiectasis pathogenesis, what is the INITIAL trigger in patients with cystic fibrosis?

A. Pseudomonas aeruginosa infection directly destroying airway walls
B. Alpha-1 antitrypsin deficiency causing unchecked elastase activity
C. CFTR dysfunction → depleted periciliary fluid → impaired mucociliary clearance → microbial colonization
D. Autoimmune destruction of bronchial cartilage
E. Traction from surrounding fibrotic parenchyma

✅ Answer: C - CFTR dysfunction → depleted periciliary fluid → impaired mucociliary clearance The vicious cycle in CF begins with CFTR dysfunction → depleted periciliary fluid layer (PCL) → ciliary collapse → failure to clear mucus → poor mucociliary clearance → microbial colonization (especially P. aeruginosa) → infection → neutrophilic inflammation + protease release → airway wall destruction → bronchiectasis → more impaired clearance → more infection (the "vicious cycle"). Alpha-1 antitrypsin deficiency = separate etiology (lower lung bronchiectasis). Traction bronchiectasis = from surrounding fibrosis pulling open airways (different mechanism).

Q3. A 50-year-old man with a right lower lobe lung abscess is prescribed metronidazole 500 mg TID as the sole antibiotic. Three weeks later he has not improved. What is the MOST likely reason for treatment failure?

A. Metronidazole does not cross the blood-brain barrier
B. Metronidazole is inactive against anaerobes in acidic abscess cavities
C. Metronidazole is not effective as a single agent for lung abscess
D. Metronidazole requires combination with rifampin for lung infections
E. The dose is subtherapeutic and should be doubled

✅ Answer: C - Metronidazole is not effective as a single agent From Dr. Platero's slides: "Metronidazole is NOT effective as a single agent" for lung abscess. Lung abscesses are typically polymicrobial - anaerobes + microaerophilic streptococci + sometimes facultative organisms. Metronidazole covers anaerobes but misses the microaerophilic component, leading to clinical failure. Correct therapy: ampicillin-sulbactam IV (beta-lactam/beta-lactamase inhibitor combination) or moxifloxacin 400 mg/d PO (equally effective). Duration: 3-14 weeks.

Q4. A 55-year-old alcoholic man develops aspiration pneumonia. Which location is MOST likely to develop a lung abscess?

A. Left lower lobe - anterior basal segment
B. Right upper lobe - anterior segment
C. Right upper lobe - posterior segment (dependent in supine position)
D. Left upper lobe - lingular segment
E. Right lower lobe - anterior basal segment

✅ Answer: C - Right upper lobe, posterior segment From Dr. Platero's slides: Primary lung abscesses occur in dependent segments:

Supine position → posterior upper lobes and superior lower lobes

Right lung > left lung (right main bronchus is less angulated → aspirated material goes right more often)

The right posterior upper lobe is the #1 location for aspiration-related lung abscess in the recumbent/supine position (e.g., alcoholic stupor). Other dependent segments: right superior lower lobe. Non-dependent segments (anterior) are less commonly affected.

Q5. Which of the following clinical findings is ESSENTIALLY DIAGNOSTIC of an anaerobic lung abscess?

A. Cavitary lesion in the right upper lobe on CXR
B. Air-fluid level within a cavity
C. Foul-smelling/putrid sputum or breath
D. Polymicrobial growth on sputum culture
E. Right-sided location of the abscess

✅ Answer: C - Foul-smelling/putrid sputum or breath From Dr. Platero's slides: "Putrid lung abscess: (+) foul-smelling breath, sputum, or empyema – essentially diagnostic of anaerobic abscess." The characteristic foul/putrid odor results from anaerobic bacterial metabolism producing short-chain fatty acids and hydrogen sulfide compounds. No other pathogen produces this putrid quality. Air-fluid levels, cavitation, and right-sided location are consistent with but not specific for anaerobic infection. Polymicrobial growth can also be seen in non-anaerobic abscesses.

Q6. A 70-year-old man with lung cancer develops a secondary lung abscess. Which organism is MOST commonly found in secondary lung abscesses?

A. Anaerobic bacteria (Bacteroides spp.)
B. Pseudomonas aeruginosa and gram-negative rods
C. Streptococcus pneumoniae
D. Fusobacterium necrophorum
E. Staphylococcus epidermidis

✅ Answer: B - Pseudomonas aeruginosa and gram-negative rods From Dr. Platero's slides - Secondary lung abscess microbiology: "Most common: Pseudomonas aeruginosa, gram-negative rods." Unlike primary lung abscesses (anaerobes from gingival crevices), secondary abscesses have a broad bacterial spectrum depending on the underlying cause. Culture is mandatory to guide targeted therapy. Anaerobes predominate in primary (aspiration) abscesses. Fusobacterium = Lemierre's syndrome. Immunosuppressed/transplant patients may have fungal infections causing secondary abscesses.

Q7. A 58-year-old woman has a lung abscess that measures 7.5 cm on CT. Despite 3 weeks of IV antibiotics, she continues to have fever and her abscess has not decreased in size. She is a poor surgical candidate due to severe COPD. What is the MOST appropriate next intervention?

A. Switch to oral moxifloxacin and continue for 14 weeks total
B. Add metronidazole to the current regimen
C. Percutaneous drainage
D. Emergency surgical resection
E. Repeat sputum cultures and wait another 2 weeks

✅ Answer: C - Percutaneous drainage From Dr. Platero's slides:

Defervescence can take up to 7 days (already exceeded - 3 weeks)

10-20% of patients may not respond to antibiotics

Abscess >6-8 cm: less likely to respond to antibiotics alone

If non-responsive to antibiotics: surgical resection OR percutaneous drainage - "preferred for poor surgical candidates"

This patient has all three criteria for intervention (>7 days fever, non-responsive, >6 cm abscess) AND is a poor surgical candidate → percutaneous CT-guided drainage is the correct answer. Adding metronidazole alone is wrong (already established it doesn't work as single agent and doesn't help in combination).

Q8. A 25-year-old male with CF is found to be 99% infertile despite normal libido and testicular size. What is the SPECIFIC anatomical reason?

A. Impaired spermatogenesis due to chronic hypoxemia
B. Complete involution of the vas deferens (CBAVD)
C. Epididymal obstruction from recurrent infections
D. Sertoli cell dysfunction from CFTR mutation
E. Hypothalamic-pituitary axis dysfunction from malnutrition

✅ Answer: B - Complete involution of the vas deferens (CBAVD) From Dr. Platero's slides: "Men: complete involution of the vas deferens and infertility (despite functioning spermatogenesis), and ~99% of males are infertile." The vas deferens requires CFTR function during embryonic development - without it, the vas deferens involutes (disappears). This is obstructive azoospermia - sperm are produced normally in the testes but cannot be delivered. TESE (testicular sperm extraction) + IVF/ICSI can allow biological fatherhood. Spermatogenesis is INTACT.

Q9. The sweat chloride test in cystic fibrosis shows markedly elevated Cl⁻ in sweat. What is the physiologic basis for this finding?

A. CFTR over-secretes chloride into sweat glands
B. Sweat ducts normally reabsorb chloride; CFTR malfunction → diminished Cl⁻ reabsorption → elevated sweat Cl⁻
C. Sweat production is increased due to autonomic dysfunction
D. CFTR mutations cause increased chloride in the blood that spills into sweat
E. Damaged skin in CF allows passive chloride efflux

✅ Answer: B - CFTR malfunction → diminished Cl⁻ reabsorption → elevated sweat Cl⁻ From Dr. Platero's slides: "Sweat ducts function: reabsorb chloride from a primary sweat secretion. Malfunction of CFTR → diminished chloride uptake from the ductular lumen → markedly elevated levels of chloride in the skin." Normal sweat duct reabsorbs Cl⁻ → dilute, low-Cl⁻ final sweat. In CF, this reabsorption fails → Cl⁻ stays in sweat → diagnostic high sweat Cl⁻ (≥60 mEq/L = positive; normal <30). This is opposite to the respiratory effect (where CFTR deficiency reduces secretion into airway lumen).

Q10. The CFTR protein functions primarily as:

A. A sodium-potassium ATPase pump in bronchial epithelium
B. A passive chloride and bicarbonate channel in apical plasma membranes of epithelial cells
C. An active chloride transporter using ATP to pump Cl⁻ against concentration gradient
D. A mucin-producing enzyme in goblet cells
E. A protease inhibitor in bronchial secretions

✅ Answer: B - Passive Cl⁻/HCO₃⁻ channel in apical plasma membranes From Dr. Platero's slides: CFTR is:

"An integral membrane protein that functions as an epithelial anion channel"

"A passive conduit for chloride and bicarbonate transport across plasma membranes"

"Situated in the apical plasma membranes of acinar and other epithelial cells"

"Regulates the amount and composition of secretion by exocrine glands"

It is NOT an active pump (ATPase) despite being an ATP-binding cassette (ABC) protein - it uses ATP binding to gate the channel (open/close) but the actual Cl⁻ flow is passive (down electrochemical gradient). It is NOT a protease inhibitor (that is alpha-1 antitrypsin).

Q11. Which genetic allele is MOST commonly associated with CF and pancreatic insufficiency?

A. G551D only
B. F508del (and other truncation alleles)
C. R117H
D. W1282X only
E. 5T splice variant

✅ Answer: B - F508del (and truncation alleles) From Dr. Platero's slides: "F508del, G551D, and truncation alleles: 'severe' defects → predictive of pancreatic insufficiency." F508del is the most common CF mutation (~70% of CF alleles worldwide). It causes misfolding of CFTR protein → retained in ER → not delivered to cell surface → no functional CFTR. Importantly: these "severe" mutations are poor predictors of overall respiratory prognosis (respiratory severity is influenced by modifier genes and environment, not just CFTR genotype). R117H and 5T = milder mutations associated with CBAVD but often not full CF.

Q12. A 38-year-old woman with a 10-year history of productive cough undergoes evaluation. CT shows central bronchiectasis with mucus plugging. She has elevated total IgE (1,800 IU/mL), peripheral eosinophilia, positive Aspergillus precipitins, and a history of asthma. According to the etiology table in the lecture, what is the LIKELY underlying etiology?

A. Cystic fibrosis (upper lobe distribution)
B. Nontuberculous mycobacteria (midlung distribution)
C. ABPA (central airway distribution)
D. Alpha-1 antitrypsin deficiency (lower lobe distribution)
E. Post-infectious bronchiectasis (lower lobe distribution)

✅ Answer: C - ABPA (central airway distribution) From Dr. Platero's slides etiology table by location:

Upper lung fields: CF, postradiation fibrosis

Lower lung fields: Chronic aspiration, end-stage fibrosis, hypogammaglobulinemia

Midlung fields: NTM/MAC, dyskinetic cilia syndrome

Central airways: ABPA, congenital causes (Mounier-Kuhn, Williams-Campbell)

Idiopathic: 25-50%

ABPA = asthma + elevated IgE + Aspergillus sensitization + central bronchiectasis = classic presentation. The immune complex deposition and inflammatory reaction specifically damages central airways.

Q13. Which of the following features distinguishes a CF pulmonary exacerbation from a typical community-acquired pneumonia?

A. Fever above 38.5°C and new lobar infiltrate
B. Productive cough and increased sputum purulence WITHOUT typical signs of infection (fever, new infiltrates)
C. Bacteremia with gram-positive organisms
D. Rapid response to amoxicillin within 48 hours
E. Bilateral pleural effusions on imaging

✅ Answer: B - Increased sputum WITHOUT typical infection signs From Dr. Platero's bronchiectasis slides: Acute exacerbations present as "changes in sputum production, increased volume and purulence" but "typical signs and symptoms of lung infection (fever, new infiltrates) not present." This distinguishes CF/bronchiectasis exacerbations from typical pneumonia. CF exacerbations are characterized by worsening cough + increased sputum + decreased FEV₁ + fatigue/weight loss - but fever and new infiltrates on CXR are NOT required and are often absent. This is why exacerbations are defined clinically, not just radiographically.

Q14. A 60-year-old patient with a primary lung abscess develops sudden worsening with fever spiking to 40°C and a new left-sided pleural effusion with pus on thoracentesis. What complication has occurred?

A. Pulmonary embolism from deep vein thrombosis
B. Empyema from pleural space extension of the lung abscess
C. Hepatic abscess from hematogenous spread
D. Pneumothorax from abscess rupture
E. Lemierre's syndrome with jugular vein thrombosis

✅ Answer: B - Empyema from pleural space extension From Dr. Platero's slides on lung abscess complications: "Pleural space extensions with development of empyema" is a listed complication of lung abscess. The abscess can rupture into the pleural space → empyema necessitans (pus in the pleural space). This requires chest tube drainage in addition to antibiotics. Other complications listed: larger cavity → pneumatoceles or bronchiectasis; life-threatening hemoptysis; massive aspiration of abscess contents. Lemierre's syndrome is a cause of lung abscess (via septic emboli), not a complication of lung abscess.

Q15. What is the MORTALITY rate of a primary vs. secondary lung abscess?

A. Primary 25-40%; Secondary 2-5%
B. Primary 2%; Secondary up to 75%
C. Both have equal mortality of approximately 10-15%
D. Primary 10%; Secondary 25%
E. Primary 5-10%; Secondary 50%

✅ Answer: B - Primary 2%; Secondary up to 75% From Dr. Platero's slides: "Mortality rates: Primary abscess: 2%; Secondary abscess: may be as [high as] 75% in some case series." This dramatic difference reflects:

Primary (aspiration, healthy host, anaerobes) = usually curable with antibiotics

Secondary (underlying malignancy, immunosuppression, resistant organisms) = underlying condition drives mortality

Poor prognostic factors: age >60, presence of aerobic bacteria, sepsis at presentation, symptom duration >8 weeks, abscess size >6 cm (these apply to ALL lung abscesses).

TOPIC 4: GRAM-NEGATIVE INFECTIONS — MENINGOCOCCAL, GONOCOCCAL, HACEK

14 MCQs

Q1. A 19-year-old college student develops fever, severe headache, and a rapidly spreading non-blanching purpuric rash. Which serogroup of N. meningitidis is most strongly associated with outbreaks in closed communities (universities, military camps) over the past 4 decades?

A. Serogroup A (meningitis belt outbreaks)
B. Serogroup B (hyperendemic disease)
C. Serogroup X (African meningitis belt)
D. Serogroup C or W (sequence type 11 clone)
E. Serogroup Y (institutional outbreaks)

✅ Answer: D - Serogroup C or W (sequence type 11 clone) From Harrison's Chapter 160: "Over the past 4 decades, such clusters have been especially strongly linked with a particular clone (sequence type 11) that is mainly associated with capsular group C or W." This clone is responsible for the majority of meningococcal clusters in closed communities (schools, colleges, universities, military training centers, refugee camps). Serogroup A = epidemic in sub-Saharan Africa. Serogroup B = hyperendemic disease (Pacific Northwest, New Zealand). Serogroup X = large outbreaks in African meningitis belt. Serogroup Y = sporadic/occasional institutional.

Q2. The Hajj pilgrimage in 2000/2001 was associated with a major meningococcal outbreak. Which serogroup was responsible, and what is the current public health response?

A. Serogroup A; MenB vaccine required
B. Serogroup W; MenACWY conjugate vaccine required for Saudi Arabia travel
C. Serogroup C; rifampin prophylaxis required for all pilgrims
D. Serogroup B; bivalent MenB vaccine required
E. Serogroup Y; no vaccination currently required

✅ Answer: B - Serogroup W; MenACWY conjugate vaccine required From Harrison's Chapter 160: "Clusters of capsular group W disease associated with the Hajj pilgrimage in 2000/2001 led to a requirement for vaccination against meningococcal disease for travel to Saudi Arabia." The required vaccine is MenACWY conjugate (covers groups A, C, W, Y). This is a mandatory requirement - pilgrims must show proof of meningococcal vaccination. Newer vaccines covering A, C, W, Y, and X are becoming available globally (X is now causing large outbreaks in the African meningitis belt).

Q3. Which of the following is MOST accurate regarding chemoprophylaxis for meningococcal disease contacts?

A. Rifampin is optimal because it eradicates carriage in >95% of cases
B. Mass prophylaxis at schools or colleges is routinely recommended
C. Ceftriaxone (single IM injection) eradicates carriage in ~97% and is safe in pregnancy
D. Fluoroquinolones are preferred in pregnancy due to their safety profile
E. Prophylaxis is given to all persons in the community during an outbreak

✅ Answer: C - Ceftriaxone single IM injection, 97% effective, safe in pregnancy From Harrison's Chapter 160:

Ceftriaxone: "97% effective in carriage eradication and can be used at all ages and in pregnancy" ✅

Rifampin: "fails to eradicate carriage in 15-20% of cases, rates of adverse events have been high, compliance is affected by 4 doses, emerging resistance" ✗ (NOT optimal)

Fluoroquinolones: NOT recommended in pregnancy; resistance reported in North America, Europe, Asia

Mass prophylaxis: NOT routinely recommended for wide communities (schools/colleges) - "limited data support population intervention, significant concerns about adverse events and resistance"

Prophylaxis restricted to: intimate/household contacts + healthcare workers with direct respiratory secretion exposure

Q4. A patient with meningococcal meningitis develops bilateral adrenal hemorrhage with refractory hypotension. What is the eponym for this syndrome?

A. Lemierre's syndrome
B. Fitz-Hugh-Curtis syndrome
C. Waterhouse-Friderichsen syndrome
D. Osler's nodes syndrome
E. Jarisch-Herxheimer reaction

✅ Answer: C - Waterhouse-Friderichsen syndrome Bilateral adrenal hemorrhage (adrenal infarction) from meningococcemia = Waterhouse-Friderichsen syndrome. Mechanism: meningococcal septicemia → DIC + intravascular thrombosis → bilateral adrenal hemorrhage → acute adrenal insufficiency → refractory hypotension. This is the mechanism behind the pathophysiology section in Harrison's - meningococcal septicemia causes shock through: capillary leak (hypovolemia) + myocardial depression + adrenal insufficiency. High PAI-1 levels → impaired fibrinolysis → DIC. Management requires hydrocortisone replacement + aggressive fluid resuscitation.

Q5. Neisseria gonorrhoeae is described as having "3 genome copies per coccal unit." What is the clinical significance of this polyploidy?

A. It makes the organism easier to identify on Gram stain
B. It enables a high level of antigenic variation and survival in the host
C. It increases the sensitivity of NAAT testing
D. It causes higher bacterial loads in infections
E. It makes the organism impossible to culture in the laboratory

✅ Answer: B - High level of antigenic variation and survival in host From Harrison's Chapter 161: "N. gonorrhoeae contains, on average, three genome copies per coccal unit; this polyploidy permits a high level of antigenic variation and the survival of the organism in its host." Multiple genome copies allow frequent recombination between copies → rapid changes in surface antigens (pili, Opa proteins) → immune evasion. This is why prior infection does NOT confer reliable protective immunity and reinfection is common. This polyploidy-driven antigenic variation is a key virulence mechanism making vaccine development difficult.

Q6. A patient presents with tenosynovitis of the right wrist, migratory polyarthralgia, and a few pustular skin lesions. She has been sexually active with multiple partners. Blood cultures are negative. What is the MOST likely diagnosis?

A. Septic arthritis from Staphylococcus aureus
B. Reactive arthritis (Reiter's syndrome) post-chlamydial infection
C. Disseminated gonococcal infection (DGI) - bacteremic form
D. HACEK endocarditis with septic emboli
E. Rheumatoid arthritis with extra-articular features

✅ Answer: C - DGI - bacteremic form From Harrison's Chapter 161: Disseminated gonococcal infection (DGI) "manifestations include skin lesions, tenosynovitis, septic arthritis." The bacteremic form (dermatitis-arthritis syndrome) presents as: tenosynovitis + migratory polyarthralgia + dermatitis (pustular/hemorrhagic skin lesions) with characteristically negative blood cultures (bacteremia is transient). The septic arthritis form of DGI = purulent monoarthritis (different presentation). Reactive arthritis has a characteristic post-infectious triad (urethritis + arthritis + conjunctivitis). HACEK = endocarditis with large vegetations.

Q7. The Rmp (Reduction Modifiable Protein) of N. gonorrhoeae is a critical virulence factor. Which mechanism explains how Rmp antibodies INCREASE susceptibility to reinfection?

A. Rmp antibodies directly enhance gonococcal uptake into macrophages
B. Rmp antibodies competitively inhibit complement fixation on the gonococcal surface
C. Rmp antibodies block the bactericidal effect of antibodies to porin and LOS
D. Rmp antibodies activate regulatory T cells that suppress anti-gonococcal immunity
E. Rmp antibodies prevent neutrophil degranulation

✅ Answer: C - Rmp antibodies block bactericidal antibodies to porin and LOS From Harrison's Chapter 161: Women infected with gonorrhea who acquire high levels of antibody to Rmp → more likely to become reinfected because "Rmp antibodies block the effect of bactericidal antibodies to porin and LOS." Rmp has little interstrain variation → Rmp antibodies potentially block killing of ALL gonococci. Rmp has homology to enterobacterial OmpA and meningococcal class 4 proteins → blocking antibodies may even arise from prior exposure to other gram-negative bacteria. This mechanism of "blocking antibodies" is a key immune evasion strategy and explains the lack of protective immunity after gonorrhea.

Q8. Which of the following is the MOST accurate reason why cefixime has been removed from first-line treatment of gonorrhea?

A. It causes severe hepatotoxicity in >10% of patients
B. Rising MICs + limited capacity to reach levels sufficiently above MICs in blood, urethra, cervix, and especially the pharynx
C. It is ineffective against intracellular forms of N. gonorrhoeae
D. It causes QT prolongation and cardiac arrhythmias
E. Resistance to cefixime cross-confers resistance to ceftriaxone

✅ Answer: B - Rising MICs + insufficient drug levels in pharynx From Harrison's Chapter 161: "The rising MICs of oral cefixime... combined with this drug's limited capacity to reach levels sufficiently higher than MICs in the blood, the urethra, the cervix, and especially the pharynx, have resulted in the removal of cefixime from the list of first-line agents." Pharyngeal gonorrhea is particularly hard to eradicate with oral cefixime - the pharynx is a natural reservoir for gonorrhea and treatment failure there perpetuates transmission. Ceftriaxone (IM) achieves levels greatly exceeding MICs at all sites. This is a pharmacokinetic, not pharmacodynamic, failure.

Q9. The HACEK organisms share which common characteristic that makes endocarditis diagnosis challenging?

A. They are all gram-positive cocci that form biofilms
B. They are fastidious, slow-growing gram-negative organisms that cause culture-negative endocarditis
C. They exclusively infect prosthetic heart valves
D. They are exclusively transmitted by inhalation of environmental spores
E. They are all resistant to beta-lactam antibiotics

✅ Answer: B - Fastidious, slow-growing, causing culture-negative endocarditis HACEK group: Haemophilus, Aggregatibacter, Cardiobacterium, Eikenella, Kingella are:

Part of normal oropharyngeal flora

Fastidious (special growth requirements)

Slow-growing → standard 5-day blood culture incubation may miss them

Classic cause of culture-negative endocarditis (before extended incubation or molecular diagnostics)

NOT exclusively prosthetic (also native valves, especially in those with preexisting valvular disease)

Most are susceptible to beta-lactams (but slow growth makes susceptibility testing difficult - beta-lactamase production may go undetected)

Q10. Aggregatibacter actinomycetemcomitans is the MOST common cause of HACEK endocarditis. Compared to Haemophilus species in HACEK, it has which distinct characteristic?

A. It causes only right-sided endocarditis
B. It is more frequently associated with prosthetic valve endocarditis
C. It is exclusively a pathogen of children under 5
D. It is resistant to all cephalosporins
E. It causes only skin and soft tissue infections, never endocarditis

✅ Answer: B - More frequently associated with prosthetic valve endocarditis From Harrison's Chapter 163: "Aggregatibacter is associated with prosthetic-valve endocarditis more often than are Haemophilus species." Aggregatibacter spp. (particularly A. actinomycetemcomitans, A. aphrophilus, A. paraphrophilus) are the most common cause of HACEK endocarditis overall. A. actinomycetemcomitans can also cause soft tissue infections and abscesses (not exclusively endocarditis). Kingella kingae = children, skeletal infections. No HACEK organism is resistant to all cephalosporins.

Q11. A 16-year-old patient needs prophylaxis after exposure to meningococcal disease. Which antibiotic from the following is specifically NOT recommended for this patient due to age restriction?

A. Ceftriaxone
B. Rifampin
C. Ciprofloxacin as treatment for active infection (not prophylaxis)
D. Amoxicillin
E. Penicillin G

✅ Answer: C - Ciprofloxacin for treatment (not prophylaxis) in <18 years From Harrison's Chapter 163 (HACEK treatment table): "Fluoroquinolones are not recommended for treatment of patients <18 years of age." However, fluoroquinolones (ciprofloxacin) CAN be used for meningococcal prophylaxis (post-exposure) in adolescents - this is an important distinction. The age restriction applies to treatment of active infections (fluoroquinolone arthropathy concern in growing cartilage), not to single-dose post-exposure prophylaxis. Ceftriaxone = safe in all ages. Rifampin = used but not optimal (15-20% failure rate).

Q12. A microbiology report shows a culture growing gram-negative diplococci that display a "hockey puck sign" on culture plates and turn pink after 48 hours of growth. It is resistant to amoxicillin. What is the organism and the mechanism of amoxicillin resistance?

A. N. gonorrhoeae - PBP2 (penA) mutation
B. N. meningitidis - altered outer membrane porin
C. Moraxella catarrhalis - beta-lactamase production
D. Haemophilus influenzae - beta-lactamase production
E. Eikenella corrodens - intrinsic resistance mechanism

✅ Answer: C - Moraxella catarrhalis - beta-lactamase production From Harrison's Chapter 163: M. catarrhalis colonies: (1) slide across agar without disruption ("hockey puck sign") - unlike Neisseria which break up; (2) after 48h growth → pink color and larger than Neisseria colonies. Resistance mechanism: "M. catarrhalis rapidly acquired β-lactamases during the 1970s and 1980s - the fastest documented spread of β-lactamase-encoding plasmids. >90% of strains now produce β-lactamase and thus resistant to amoxicillin." Treatment: amoxicillin-clavulanate, extended-spectrum cephalosporins, azithromycin, TMP-SMX, fluoroquinolones.

Q13. A 28-year-old woman with PID has perihepatitis diagnosed on laparoscopy with "violin-string adhesions" between the liver capsule and peritoneum. What is the correct name for this syndrome and its causative organisms?

A. Waterhouse-Friderichsen syndrome; N. meningitidis
B. Fitz-Hugh-Curtis syndrome; N. gonorrhoeae or Chlamydia trachomatis
C. Lemierre's syndrome; Fusobacterium necrophorum
D. Osler-Weber-Rendu syndrome; vascular malformations
E. Jarisch-Herxheimer reaction; Treponema pallidum

✅ Answer: B - Fitz-Hugh-Curtis syndrome; N. gonorrhoeae or Chlamydia trachomatis From Harrison's Chapter 161: Perihepatitis is listed as a local complication of gonorrhea in females. Fitz-Hugh-Curtis syndrome: organisms spread from fallopian tubes → peritoneum → liver capsule → perihepatitis → "violin-string adhesions" on laparoscopy between liver surface and peritoneum. Also caused by Chlamydia trachomatis. Presents as: RUQ pain + cervical motion tenderness + elevated liver enzymes. Waterhouse-Friderichsen = meningococcal bilateral adrenal hemorrhage. Lemierre's = F. necrophorum + jugular vein thrombosis.

Q14. For HACEK endocarditis, first-line therapy is ceftriaxone 2g/d. A patient is allergic to beta-lactams. Which alternative carries a specific warning about use in pediatric patients?

A. Vancomycin - causes red man syndrome
B. Levofloxacin 750 mg/d - not recommended in patients <18 years of age
C. Metronidazole - inactive against HACEK organisms
D. Azithromycin - QT prolongation risk
E. Doxycycline - tooth discoloration in children

✅ Answer: B - Levofloxacin not recommended in <18 years From Harrison's Chapter 163 treatment table: For HACEK endocarditis, levofloxacin 750 mg/d is listed as an alternative to ceftriaxone for beta-lactam-intolerant patients, with the note: "Fluoroquinolones are not recommended for treatment of patients <18 years of age." This is due to concerns about fluoroquinolone effects on developing cartilage (arthropathy in animal models). Data on levofloxacin for HACEK endocarditis treatment are also described as "limited." Metronidazole has no activity against aerobic/facultative gram-negative HACEK organisms. Vancomycin = gram-positive coverage only.

TOPIC 5: FUNGAL INFECTIONS

14 MCQs

Q1. A 35-year-old HIV patient (CD4 count 55 cells/μL) presents with 3 weeks of worsening headache, mild fever, and personality changes. CSF shows: WBC 3 cells/μL (normal), protein slightly elevated, glucose normal. India ink reveals encapsulated yeast. Which of the following is MOST correct?

A. Normal WBC in CSF rules out meningitis in this context
B. The minimal inflammation is explained by the polysaccharide capsule suppressing the host immune response
C. High CSF WBC would be expected given the severe infection
D. India ink is insensitive and should not be relied upon for diagnosis
E. This patient requires no treatment as the infection appears mild

✅ Answer: B - Polysaccharide capsule suppresses host immune response Cryptococcal meningoencephalitis is notorious for causing minimal CSF inflammation despite serious infection. This is a key diagnostic trap - a near-normal CSF cell count does NOT rule out cryptococcal meningitis in immunocompromised patients. The large polysaccharide capsule of C. neoformans physically inhibits phagocytosis AND dampens inflammatory cytokine responses. India ink is positive in 50-80% of HIV-associated cryptococcal meningitis (moderate sensitivity). Cryptococcal antigen (CrAg) in CSF/serum is >95% sensitive and specific - the best test. Treatment is urgently required regardless of "mild" appearing CSF.

Q2. A 62-year-old diabetic in DKA presents with right-sided facial pain, proptosis, and a black necrotic lesion on the hard palate. Biopsy of the necrotic tissue is performed. Which microscopic finding is EXPECTED?

A. Narrow, septate hyphae branching at 45° angles
B. Encapsulated yeast cells with a wide polysaccharide halo
C. Broad, non-septate (pauciseptate), ribbon-like hyphae with right-angle branching
D. Budding yeast with pseudohyphae
E. Round spherules containing endospores

✅ Answer: C - Broad, non-septate, ribbon-like hyphae with right-angle branching Mucormycosis (caused by Mucor, Rhizopus, Lichtheimia) - the classic microscopic finding:

Broad (10-15 μm wide)

Non-septate / pauciseptate (rare septa)

Ribbon-like (collapsed, irregular walls)

Right-angle (90°) branching

Compare to Aspergillus: narrow (2-4 μm), septate, 45° angle branching. This distinction is exam-critical. DKA + black necrotic eschar = Mucormycosis until proven otherwise. Cryptococcus = encapsulated yeast (India ink). Candida = budding yeast + pseudohyphae. Coccidioides = spherules with endospores.

Q3. A 25-year-old leukemia patient (ANC = 80 cells/μL for 3 weeks) is started on empiric voriconazole for suspected invasive aspergillosis. CT shows nodules with halo sign. Two days later, the infectious disease team discovers the patient is also on rifampin for TB prophylaxis. What is the PRIMARY concern?

A. Additive nephrotoxicity from both drugs
B. Rifampin is a potent CYP450 inducer → dramatically reduces voriconazole plasma levels → subtherapeutic antifungal coverage
C. Voriconazole increases rifampin levels causing rifampin toxicity
D. Both drugs prolong the QT interval with additive cardiac risk
E. Rifampin causes neutropenia that will worsen the underlying immunosuppression

✅ Answer: B - Rifampin induces CYP450 → subtherapeutic voriconazole levels This is an absolute contraindication for the combination. Rifampin is one of the most potent CYP450 inducers (CYP3A4, CYP2C19) → accelerates metabolism of voriconazole → plasma voriconazole levels drop by up to 90% → antifungal treatment failure in a critically ill immunocompromised patient. Options: switch to liposomal amphotericin B (not CYP-metabolized) or reconsider the rifampin. Isavuconazole is similarly affected. This drug-drug interaction can be life-threatening in IPA.

Q4. A 44-year-old woman who recently returned from Arizona develops cough, fever, right-sided pleuritic chest pain, and a tender erythematous rash on her shins. Serology for Coccidioides IgM is positive. What does the erythema nodosum indicate about her prognosis?

A. It indicates disseminated coccidioidomycosis requiring amphotericin B urgently
B. It is a marker of a robust immune response and is associated with a BETTER prognosis
C. It indicates bone and joint involvement requiring prolonged therapy
D. It predicts CNS dissemination within 2 weeks
E. It requires skin biopsy to confirm the diagnosis of coccidioidomycosis

✅ Answer: B - Robust immune response; better prognosis Erythema nodosum in coccidioidomycosis (and other fungal/mycobacterial infections) represents a hypersensitivity (immune) reaction - the body mounting a strong immune response against the organism. It is NOT a sign of dissemination but rather of effective immune containment. Patients with erythema nodosum or erythema multiforme during primary coccidioidomycosis have a better prognosis and are less likely to develop dissemination. High risk for dissemination: immunocompromised, pregnant women (especially 3rd trimester), African-American and Filipino individuals (genetic susceptibility), elderly.

Q5. A 32-year-old asthmatic woman has recurrent episodes of wheezing, central bronchiectasis on CT, total IgE of 1,900 IU/mL, and Aspergillus-specific IgE. Which combination of hypersensitivity reactions is responsible for ABPA?

A. Type I and Type II (IgG-mediated cytotoxicity)
B. Type I (IgE-mediated) and Type III (immune complex-mediated)
C. Type III and Type IV (delayed-type hypersensitivity)
D. Type II (cytotoxic) and Type IV (cell-mediated)
E. Type I only (atopic IgE response)

✅ Answer: B - Type I and Type III ABPA involves two hypersensitivity mechanisms:

Type I (IgE-mediated / immediate): Aspergillus antigens bind specific IgE on mast cells → degranulation → bronchoconstriction + elevated total IgE + Aspergillus-specific IgE → responsible for asthma component

Type III (immune complex-mediated): IgG antibodies to Aspergillus form immune complexes → complement activation → neutrophil recruitment → tissue damage → central bronchiectasis + mucus plugs

Type IV (cell-mediated/delayed) is NOT primarily involved. This dual mechanism explains why ABPA requires both corticosteroids (suppress immune damage - both Type I and III) AND itraconazole (reduce fungal antigen burden).

Q6. Which antifungal drug class has NO activity against Cryptococcus neoformans?

A. Polyenes (amphotericin B)
B. Azoles (fluconazole)
C. Flucytosine (5-FC)
D. Echinocandins (caspofungin, micafungin)
E. Combination of polyene + flucytosine

✅ Answer: D - Echinocandins Echinocandins (caspofungin, micafungin, anidulafungin) target β-1,3-D-glucan synthase → inhibit fungal cell wall synthesis. Cryptococcus neoformans has very low levels of β-1,3-D-glucan in its cell wall → echinocandins have no meaningful clinical activity against Cryptococcus. The standard treatment for cryptococcal meningitis is amphotericin B + flucytosine (induction) → fluconazole (consolidation/maintenance). Echinocandins excel against Candida (first-line invasive) and Aspergillus (salvage/combination). Never use echinocandin alone for cryptococcosis.

Q7. A patient with a known prior TB cavity now presents with recurrent hemoptysis. CT shows a round mobile mass within the cavity. The mass shifts with patient position changes. Serum galactomannan is negative. What is the MOST appropriate first intervention for hemoptysis control?

A. Immediate high-dose voriconazole
B. IV amphotericin B for 2 weeks
C. Bronchial artery embolization
D. Surgical resection of the affected lobe as first-line
E. Observation as the lesion is benign

✅ Answer: C - Bronchial artery embolization This describes a pulmonary aspergilloma (fungus ball in pre-existing TB cavity). The mobile mass that shifts with gravity + air crescent sign (Monod sign) = classic aspergilloma. Galactomannan is typically negative (not IPA). For hemoptysis from aspergilloma:

First-line: Bronchial artery embolization (BAE) - controls bleeding in 80-90%

Surgery (lobectomy): reserved for massive/refractory bleeding when technically feasible

Antifungals: limited evidence for aspergilloma; poor drug penetration into cavity

Observation is acceptable ONLY for asymptomatic aspergillomas (no hemoptysis)

Q8. Histoplasma capsulatum is a dimorphic fungus. What does "dimorphic" mean in the clinical context and how does this relate to pathogenesis?

A. It infects two organs simultaneously (lungs and liver)
B. It exists as a mold in the environment at ambient temperatures and converts to yeast form at 37°C in human tissues
C. It has two distinct life cycles - sexual and asexual
D. It causes two distinct clinical syndromes - pulmonary and systemic
E. It is transmitted by two routes - inhalation and ingestion

✅ Answer: B - Mold in environment; yeast at 37°C in human tissues Dimorphic fungi undergo thermal dimorphism: they exist as multicellular molds (with conidia/spores) in the environment at room temperature (25°C), and convert to unicellular yeast forms when they enter human tissues at body temperature (37°C). This temperature-dependent morphologic switch is critical for pathogenesis - the yeast form is what survives and replicates inside macrophages. Other dimorphic fungi: Blastomyces, Coccidioides, Paracoccidioides, Sporothrix. Lab personnel are warned to handle cultures carefully - the mold form (at 25°C) produces infectious airborne conidia (biosafety hazard).

Q9. A 55-year-old post-renal transplant patient develops candidemia. Blood cultures are positive for Candida species. Which of the following interventions is as important as starting antifungal therapy?

A. Starting prophylactic TMP-SMX
B. Adding voriconazole to cover mold infections
C. Removing the central venous catheter
D. Performing bone marrow biopsy to assess for dissemination
E. Starting high-dose corticosteroids to suppress inflammation

✅ Answer: C - Removing the central venous catheter Central venous catheter removal is a critical step in managing candidemia - as important as antifungal therapy. Candida forms biofilms on catheter surfaces that are impenetrable to antifungals. Leaving the catheter in place → persistent bacteremia/fungemia → treatment failure → seeding of distant sites (eyes, heart, bones, CNS). Guidelines recommend: remove/replace the CVC as soon as possible once candidemia is identified. Treatment: echinocandin (caspofungin/micafungin) = first-line. Also: dilated fundoscopic exam urgently (rule out endophthalmitis which changes treatment duration).

Q10. Which Candida species is intrinsically resistant to fluconazole and requires an echinocandin or voriconazole for treatment?

A. C. albicans
B. C. parapsilosis
C. C. tropicalis
D. C. krusei (now Pichia kudriavzevii)
E. C. glabrata (now Nakaseomyces glabrata)

✅ Answer: D - C. krusei C. krusei is intrinsically resistant to fluconazole (and also reduced susceptibility to other azoles). Must use echinocandin (caspofungin, micafungin) or voriconazole. Memorize the resistance pattern:

C. albicans: Usually fluconazole-susceptible ✅

C. glabrata: Dose-dependent susceptibility to fluconazole; often needs higher doses or echinocandin

C. krusei: Intrinsically fluconazole-resistant → echinocandin or voriconazole

C. parapsilosis: Often echinocandin-resistant (biofilm-forming, common on catheters/neonates); fluconazole usually works

C. auris: Often multidrug-resistant (emerging pathogen)

Q11. Aspergillus terreus is distinct from other Aspergillus species in which important way?

A. It preferentially infects the sinuses rather than lungs
B. It is intrinsically resistant to amphotericin B
C. It is the only Aspergillus species causing ABPA
D. It requires echinocandins as first-line therapy
E. It only causes infection in immunocompetent hosts

✅ Answer: B - Intrinsically resistant to amphotericin B A. terreus is unique among the major Aspergillus species in being intrinsically resistant to amphotericin B (both conventional and liposomal formulations). This is a clinically critical fact because if IPA fails initial voriconazole therapy and the clinician switches to amphotericin B, infections due to A. terreus will not respond. A. terreus should be treated with voriconazole, isavuconazole, or posaconazole. A. fumigatus = most common cause of IPA. A. flavus = sinusitis, keratitis. A. niger = otomycosis. Only A. fumigatus and A. flavus mainly cause ABPA (not exclusively A. terreus).

Q12. A patient with AIDS develops cryptococcal meningitis (opening pressure 42 cm H₂O) and is started on appropriate antifungal therapy. Three days later he develops worsening headache. CT shows no new lesions or hydrocephalus. What is the MOST appropriate management of the elevated ICP?

A. Add dexamethasone 0.4 mg/kg/day for 4 days
B. Perform serial therapeutic lumbar punctures to reduce opening pressure
C. Start mannitol 0.5 g/kg IV every 6 hours
D. Reduce antifungal dose to decrease fungal die-off reaction
E. Insert ventriculoperitoneal shunt immediately

✅ Answer: B - Serial therapeutic lumbar punctures For elevated ICP in cryptococcal meningitis, the management is serial therapeutic lumbar punctures - remove enough CSF to reduce opening pressure to ≤20 cm H₂O or by 50%. This is performed daily if needed until ICP is controlled. Key points:

Corticosteroids (dexamethasone) are NOT routinely recommended for cryptococcal meningitis ICP (unlike bacterial meningitis where they reduce inflammation) - steroids may worsen fungal disease

Mannitol has limited evidence in this context

VP shunt: for refractory ICP uncontrolled by serial LPs

"Reducing antifungal dose" = wrong and dangerous

Q13. A 40-year-old construction worker develops progressive upper lobe cavitary lesions resembling TB. He is from Arizona. Serum IgG (Coccidioides complement fixation) titer is 1:64 (rising). He has no immunosuppression. Which statement about his management is MOST correct?

A. No treatment needed - coccidioidomycosis is always self-limited
B. Fluconazole or itraconazole for mild/moderate disease; amphotericin B for severe disease
C. Rifampin + isoniazid + pyrazinamide for 6 months (treat as TB empirically)
D. Voriconazole is first-line for coccidioidomycosis
E. Echinocandin therapy is appropriate for pulmonary coccidioidomycosis

✅ Answer: B - Fluconazole or itraconazole (mild); amphotericin B (severe) Coccidioidomycosis management:

Asymptomatic / mild primary pulmonary: Often self-limited in immunocompetent; antifungal may not be needed

Symptomatic / chronic cavitary / disseminated: Fluconazole or itraconazole (azoles = first-line for non-severe disease)

Severe/disseminated/meningitis: Amphotericin B initially → step-down to azole

Meningitis: Fluconazole lifelong suppression (intrathecal amphotericin for refractory cases)

Voriconazole: Not primary agent (used for Aspergillus/salvage)

Echinocandins: No meaningful activity against Coccidioides

Rising complement fixation titers indicate dissemination risk

Q14. A 48-year-old man with a history of sarcoidosis (now quiescent) presents with 8 months of progressive weight loss, low-grade fever, and chronic productive cough. CT shows slowly expanding cavities in bilateral upper lobes with no acute air-fluid levels. Serum Aspergillus IgG is positive (precipitins). Galactomannan is negative. He has no neutropenia.

Q: What type of aspergillosis does this represent, and how does it differ from IPA?

A. Invasive pulmonary aspergillosis (IPA) - treat urgently with IV voriconazole
B. Aspergilloma - no treatment needed, just observation
C. Chronic pulmonary aspergillosis (CPA) - treat with long-term oral azole
D. ABPA - treat with systemic steroids and itraconazole
E. Allergic Aspergillus sinusitis - ENT referral

✅ Answer: C - Chronic pulmonary aspergillosis (CPA) CPA vs IPA comparison:

Feature IPA CPA
Host Neutropenic, severely immunocompromised Structural lung disease (sarcoidosis, COPD, prior TB); mild immune dysfunction
Onset Acute (days-weeks) Subacute-chronic (months-years)
Galactomannan High (positive) Low/negative
Aspergillus IgG Negative (no immune response) Positive (precipitins)
Imaging Halo sign, rapidly progressing Slowly progressive cavitation
Treatment IV voriconazole urgently Long-term oral itraconazole/voriconazole (1-2+ years)

This patient fits CPA: structural lung disease (sarcoidosis) + chronic progressive cavitation + positive IgG precipitins + negative galactomannan + NO severe immunosuppression.

Feature	IPA	CPA
Host	Neutropenic, severely immunocompromised	Structural lung disease (sarcoidosis, COPD, prior TB); mild immune dysfunction
Onset	Acute (days-weeks)	Subacute-chronic (months-years)
Galactomannan	High (positive)	Low/negative
Aspergillus IgG	Negative (no immune response)	Positive (precipitins)
Imaging	Halo sign, rapidly progressing	Slowly progressive cavitation
Treatment	IV voriconazole urgently	Long-term oral itraconazole/voriconazole (1-2+ years)

📊 SCORE YOURSELF

Score Range	Interpretation
90-100%	Excellent - exam-ready
75-89%	Good - review your weak topics
60-74%	Fair - revisit teaching notes + retake
<60%	Need more review - re-read the notes first

Total questions: 70 MCQs across 5 topics

Want me to create a timed mock exam pulling mixed questions from all 5 topics, or generate fill-in-the-blank tables for drug mechanisms and treatments? Just ask!

This is a shared conversation. Sign in to Orris to start your own chat.